NZ785215A - Isolating intracellular polysaccharides from fungi - Google Patents
Isolating intracellular polysaccharides from fungiInfo
- Publication number
- NZ785215A NZ785215A NZ785215A NZ78521522A NZ785215A NZ 785215 A NZ785215 A NZ 785215A NZ 785215 A NZ785215 A NZ 785215A NZ 78521522 A NZ78521522 A NZ 78521522A NZ 785215 A NZ785215 A NZ 785215A
- Authority
- NZ
- New Zealand
- Prior art keywords
- fermentation
- media
- kda
- biomass
- days
- Prior art date
Links
- 150000004676 glycans Polymers 0.000 title claims abstract description 214
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 214
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 214
- 150000004804 polysaccharides Polymers 0.000 title claims abstract description 75
- 241000233866 Fungi Species 0.000 title claims abstract description 24
- 230000003834 intracellular Effects 0.000 title claims abstract description 14
- 238000000855 fermentation Methods 0.000 claims abstract description 168
- 230000004151 fermentation Effects 0.000 claims abstract description 167
- 239000002028 Biomass Substances 0.000 claims abstract description 110
- 238000001914 filtration Methods 0.000 claims abstract description 20
- 239000011148 porous material Substances 0.000 claims abstract description 9
- 239000002609 media Substances 0.000 claims description 127
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 80
- 239000008103 glucose Substances 0.000 claims description 80
- 239000000284 extract Substances 0.000 claims description 46
- 238000000605 extraction Methods 0.000 claims description 37
- 239000000203 mixture Substances 0.000 claims description 31
- 238000007792 addition Methods 0.000 claims description 23
- 235000007164 Oryza sativa Nutrition 0.000 claims description 18
- 235000009566 rice Nutrition 0.000 claims description 18
- 235000010469 Glycine max Nutrition 0.000 claims description 17
- 241000390476 Ganoderma lingzhi Species 0.000 claims description 16
- 239000001888 Peptone Substances 0.000 claims description 16
- 108010080698 Peptones Proteins 0.000 claims description 16
- 235000019319 peptone Nutrition 0.000 claims description 16
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 14
- 229910052760 oxygen Inorganic materials 0.000 claims description 14
- 239000001301 oxygen Substances 0.000 claims description 14
- 241000894007 species Species 0.000 claims description 14
- 239000007836 KH2PO4 Substances 0.000 claims description 13
- GNSKLFRGEWLPPA-UHFFFAOYSA-M Monopotassium phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 13
- 239000002518 antifoaming agent Substances 0.000 claims description 13
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 13
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 13
- 239000004615 ingredient Substances 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 230000024001 sorocarp development Effects 0.000 claims description 6
- 241000222355 Trametes versicolor Species 0.000 claims description 4
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- 244000251953 Agaricus brunnescens Species 0.000 claims description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 3
- 240000006499 Flammulina velutipes Species 0.000 claims description 3
- 235000016640 Flammulina velutipes Nutrition 0.000 claims description 3
- 240000000588 Hericium erinaceus Species 0.000 claims description 3
- 235000007328 Hericium erinaceus Nutrition 0.000 claims description 3
- 240000002853 Nelumbo nucifera Species 0.000 claims description 3
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 3
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 3
- 241000222481 Schizophyllum commune Species 0.000 claims description 3
- 241000001727 Tropicoporus linteus Species 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 241000221377 Auricularia Species 0.000 claims description 2
- 240000004997 Coprinus comatus Species 0.000 claims description 2
- 235000004439 Coprinus comatus Nutrition 0.000 claims description 2
- 240000001080 Grifola frondosa Species 0.000 claims description 2
- 235000007710 Grifola frondosa Nutrition 0.000 claims description 2
- 240000005995 Laetiporus sulphureus Species 0.000 claims description 2
- 235000007714 Laetiporus sulphureus Nutrition 0.000 claims description 2
- 240000000599 Lentinula edodes Species 0.000 claims description 2
- 235000001715 Lentinula edodes Nutrition 0.000 claims description 2
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 2
- 235000007685 Pleurotus columbinus Nutrition 0.000 claims description 2
- 240000001462 Pleurotus ostreatus Species 0.000 claims description 2
- 235000001603 Pleurotus ostreatus Nutrition 0.000 claims description 2
- 230000002538 fungal Effects 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 241000414067 Inonotus obliquus Species 0.000 claims 1
- 240000007594 Oryza sativa Species 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 59
- 238000004458 analytical method Methods 0.000 description 46
- 238000000034 method Methods 0.000 description 39
- 229920002498 Beta-glucan Polymers 0.000 description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 33
- 239000000523 sample Substances 0.000 description 31
- 238000004128 high performance liquid chromatography Methods 0.000 description 27
- 229920001503 Glucan Polymers 0.000 description 26
- 239000006228 supernatant Substances 0.000 description 24
- 238000004519 manufacturing process Methods 0.000 description 19
- 241000209094 Oryza Species 0.000 description 17
- 238000011143 downstream manufacturing Methods 0.000 description 17
- 238000003306 harvesting Methods 0.000 description 17
- 239000012528 membrane Substances 0.000 description 17
- 238000001542 size-exclusion chromatography Methods 0.000 description 17
- 238000005273 aeration Methods 0.000 description 16
- 239000007787 solid Substances 0.000 description 16
- 150000001720 carbohydrates Chemical class 0.000 description 15
- 235000014633 carbohydrates Nutrition 0.000 description 15
- 239000008188 pellet Substances 0.000 description 13
- 229910052564 epsomite Inorganic materials 0.000 description 11
- 238000001223 reverse osmosis Methods 0.000 description 11
- FYGDTMLNYKFZSV-WFYNLLPOSA-N (2S,3R,4S,5S,6R)-2-[(2R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-WFYNLLPOSA-N 0.000 description 10
- 229920000310 Alpha glucan Polymers 0.000 description 10
- 239000012141 concentrate Substances 0.000 description 10
- 239000011159 matrix material Substances 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 235000008504 concentrate Nutrition 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 238000001556 precipitation Methods 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 238000005187 foaming Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 230000003247 decreasing Effects 0.000 description 7
- 238000005755 formation reaction Methods 0.000 description 7
- 239000011777 magnesium Substances 0.000 description 7
- 238000000386 microscopy Methods 0.000 description 7
- 239000012466 permeate Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000012465 retentate Substances 0.000 description 7
- 150000003648 triterpenes Chemical class 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 229940035295 Ting Drugs 0.000 description 6
- 238000011109 contamination Methods 0.000 description 6
- 238000011081 inoculation Methods 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- 238000005070 sampling Methods 0.000 description 6
- 238000000527 sonication Methods 0.000 description 6
- 239000006172 buffering agent Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 239000006260 foam Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 238000000569 multi-angle light scattering Methods 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 229940088598 Enzyme Drugs 0.000 description 4
- BJHIKXHVCXFQLS-UYFOZJQFSA-N Fructose Natural products OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 4
- 241000222336 Ganoderma Species 0.000 description 4
- GUBGYTABKSRVRQ-YOLKTULGSA-N Maltose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@H]1CO)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 GUBGYTABKSRVRQ-YOLKTULGSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000000105 evaporative light scattering detection Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000001965 increased Effects 0.000 description 4
- 238000011020 pilot scale process Methods 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
- 238000003998 size exclusion chromatography high performance liquid chromatography Methods 0.000 description 4
- 229940041514 Candida albicans extract Drugs 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000282619 Hylobates lar Species 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002708 enhancing Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000012092 media component Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 3
- 235000011007 phosphoric acid Nutrition 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 2
- 241000229754 Iva xanthiifolia Species 0.000 description 2
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 2
- SRBFZHDQGSBBOR-SQOUGZDYSA-N Xylose Natural products O[C@@H]1CO[C@@H](O)[C@@H](O)[C@@H]1O SRBFZHDQGSBBOR-SQOUGZDYSA-N 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- 230000003466 anti-cipated Effects 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 238000005842 biochemical reaction Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000001963 growth media Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 230000002035 prolonged Effects 0.000 description 2
- 230000002829 reduced Effects 0.000 description 2
- 230000000717 retained Effects 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 244000028550 Auricularia auricula Species 0.000 description 1
- 235000000023 Auricularia auricula Nutrition 0.000 description 1
- 101700010451 CELB Proteins 0.000 description 1
- 241000222356 Coriolus Species 0.000 description 1
- GZCGUPFRVQAUEE-KCDKBNATSA-N D-(+)-Galactose Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L Dipotassium phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 241000272184 Falconiformes Species 0.000 description 1
- 101700041462 GUX2 Proteins 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 241000222689 Laetiporus Species 0.000 description 1
- 241001307210 Pene Species 0.000 description 1
- 229940072417 Peroxidase Drugs 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108090000437 Peroxidases Proteins 0.000 description 1
- 108010078762 Protein Precursors Proteins 0.000 description 1
- 102000014961 Protein Precursors Human genes 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 241000822135 Ula Species 0.000 description 1
- 229960003487 Xylose Drugs 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 230000000711 cancerogenic Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 101700046922 cex Proteins 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012468 concentrated sample Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000003111 delayed Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002255 enzymatic Effects 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- -1 glucose) Chemical class 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000000977 initiatory Effects 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 230000000670 limiting Effects 0.000 description 1
- 150000002632 lipids Chemical group 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 1
- 230000000873 masking Effects 0.000 description 1
- 230000002503 metabolic Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000007431 microscopic evaluation Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 238000005020 pharmaceutical industry Methods 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000011176 pooling Methods 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 230000001954 sterilising Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N α-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
Abstract
The disclosure relates to a method for isolating intracellular polysaccharides from fungi comprising inoculating fungi into a fermentation medium, wherein the fermentation medium is subjected to agitation; extracting one or more polysaccharides from the fermentation media by filtration, wherein the filtration has a pore size of any one or more of 1 to 5 kDa, 10 to 20 kDa, and/or 100 to 200 kDa, wherein the polysaccharides are extracted after about 3 or about 12 days of fermentation, to produce greater than 2% polysaccharide by weight of mycelium biomass. filtration has a pore size of any one or more of 1 to 5 kDa, 10 to 20 kDa, and/or 100 to 200 kDa, wherein the polysaccharides are extracted after about 3 or about 12 days of fermentation, to produce greater than 2% polysaccharide by weight of mycelium biomass.
Description
ING INTRACELLULAR POLYSACCHARIDES FROM FUNGI
FIELD OF THE INVENTION
The present invention relates to a method for isolating intracellular
polysaccharides from fungi.
BACKGROUND TO THE INVENTION
ically, manufacturing of pharmaceutical products has had a
considerable social and environmental footprint. It has relied on the use of volatile
organic solvents, many of which are carcinogenic and toxic. Further, many synthetic
processes require large quantities of energy, and generate unnecessary waste.
Extracting the pharmacologically active component from l s
offers a r alternative to traditional synthesis. If the active ient can be
harvested from a species of fungi or bacteria, it allows for the use of more efficient and
sustainable natural processes such as fermentation.
Fermentation is traditionally performed in aqueous environments, making
the discharge environmentally benign. It also requires considerably less energy, as the
biochemical conversions are performed by. As corporate social responsibility becomes
more prominent, and the world’s nmental position more precarious, pursuit of such
processes may be of increasing commercial value.
It is an object of the present invention to isolating intracellular
polysaccharides from fungi, to overcome any of the above-mentioned disadvantages, or
to at least provide the public with a useful .
SUMMARY OF THE ION
In a first aspect there is described a method for isolating intracellular
polysaccharides from fungi comprising
inoculating fungi into a fermentation medium, wherein the fermentation
medium is ted to agitation,
extracting one or more polysaccharides from the fermentation media by
filtration, wherein the filtration has a pore size of
a) about 1 to 5 kDa,
b) about 10 to 20 kDa,
c) about 100 to 200 kDa,
d) or any combination of (a) to (c), and
wherein the polysaccharides are extracted after about 3 to about 12 days of
fermentation, to produce greater than 2% polysaccharide by weight of mycelium
biomass.
In a further aspect there is described a method for isolating intracellular
polysaccharides from fungi comprising
inoculating fungi into a fermentation , wherein the fermentation
medium is subjected to agitation, wherein the agitation exerts a shear force
of about 100 to about 1000 s-1,
isolating mycelium from the fermentation medium,
ting one or more polysaccharides from the mycelium by filtration,
wherein the filtration has a pore size of
a) about 1 to 5 kDa,
b) about 10 to 20 kDa,
c) about 100 to 200 kDa,
d) or any combination of (a) to (c), and
wherein the polysaccharides are extracted after about 3 to about 12 days of
fermentation, to produce greater than 2% polysaccharide by weight of mycelium
biomass.
In a r aspect there is described a method for isolating ellular
polysaccharides from fungi comprising
ating fungi into a fermentation medium, n the fermentation
medium
(i) is periodically dosed with a sugar at a rate of about 15 to 30 g/L of
medium,
(ii) is subjected to agitation, or
(iii) both (i) and (ii),
extracting one or more polysaccharides from the fermentation media by
filtration, wherein the filtration has a pore size of
b) about 1 to 5 kDa,
c) about 10 to 20 kDa,
d) about 100 to 200 kDa,
e) or any combination of (a) to (c), and
n the polysaccharides are extracted after about 3 to about 12 days of
fermentation, to produce greater than 2% polysaccharide by weight of mycelium
biomass.
In a first aspect there is described a method for isolating intracellular
polysaccharides from fungi comprising
inoculating fungi into a fermentation medium that comprises about 30 to
about 50 g/L of a sugar, wherein the tation medium is subjected to
agitation,
extracting one or more polysaccharides from the fermentation media by
filtration, wherein the filtration has a pore size of
b) about 1 to 5 kDa,
c) about 10 to 20 kDa,
d) about 100 to 200 kDa,
e) or any combination of (a) to (c), and
wherein the polysaccharides are extracted after about 3 to about 12 days of
fermentation, to produce greater than 2% polysaccharide by weight of mycelium
In a further aspect there is described an isolate from a fungal biomass, the
isolate comprising one or more polysaccharides having a molecular mass of
a) about 1 to 5 kDa,
b) about 10 to 20 kDa,
c) about 100 to 200 kDa,
d) or any ation of (a) to (c).
In one embodiment the fermentation medium initially comprises 30, 35, 40,
45, 50 g/L of a sugar, and suitable ranges may be selected from between any of these
values. Preferably the sugar is glucose.
In one embodiment the dosing of the media with sugar achieves a ratio of
carbon to nitrogen of about 1:3.
In one embodiment the dosing of the media with sugar achieves a
concentration of sugar in the media of about 20 g/L.
In one embodiment the sugar is provided to the media every 24 hours.
In one embodiment the sugar is first ed to the media after 24 hours
from inoculation.
In one ment the sugar is glucose.
In one embodiment the agitation is high shear mixing.
In one embodiment the shear force is about 100 to about 1000 s-1 at 20° C.
In one embodiment the fermentation is carried out at about 25 to about 35°
C, and suitable ranges may be selected from n any of these values.
In one embodiment the fungi is a mushroom s.
In one embodiment the mushroom species may be selected fromInonotus
obliquus, Trametes versicolor, (also known as Coriolus olor), Lentinula edodes,
Hericium erinaceus, eps sinensis, Grifola frondosa, Schizophyllum commune,
Flammulina velutipes, Pleurotus ostreatus, Agaricus bisporus, Auricularia la,
us comatus, Phellinus linteus, or Laetiporus sulphureus.
In one embodiment the mushroom species is selected fromGanoderma
lingzhi.
In one ment the mycelia comes from seed culture, and wherein the
seed e is first expanded.
In one embodiment the concentration of seed culture at the beginning of
fermentation is about 2 to about 6% by volume, and suitable ranges may be ed
from between any of these values.
In one embodiment the seed culture is a combination of pre-existing and
expanded seed culture.
In one embodiment the inoculated media is incubated for up to 7 days.
In one embodiment the inoculated media is stirred.
In one embodiment the inoculated media is stirred at about 80 to 160 RPM,
and suitable ranges may be selected from between any of these values.
In one embodiment the media comprises:
a) about 30 to 50 g/L glucose,
b) about 2 to 6 g/L soy peptone,
c) about 1 to 3 g/L KH2PO4,
d) about 0.5 to 2 g/L MgSO4·7H2O, or
e) any combination of (a) to (d).
In one embodiment the method comprises the addition of insoluble
ingredient.
In one embodiment about 0.5 to about 4% w/v of insoluble ingredient, and
suitable ranges may be selected from between any of these values.
In one embodiment the insoluble ient is lotus ground rice bran.
In one embodiment the vessel used for fermentation is a bioreactor.
In one embodiment the method ls any one or more parameters
ed from pH, dissolved oxygen, aeration, and shear force.
In one embodiment the mycelia is harvested before fruiting body formation.
In one ment the pH of the media is about 3 to 5, and suitable ranges
may be selected from between any of these values.
In one embodiment the level of oxygen in the fermentation mixture may be
about 20 to about 30%, and suitable ranges may be selected from between any of these
values.
In one embodiment the addition of an anti-foam agent to the media.
In one embodiment the biomass is dried prior to extraction.
In one embodiment the method extracts at least 5% polysaccharide per dry
weight of the biomass.
It is intended that reference to a range of numbers sed herein (for
example, 1 to 10) also orates reference to all rational numbers within that range
(for example, 1, 1.1, 2, 3, 3.9, 4, 5, 6, 6.5, 7, 8, 9 and 10) and also any range of
rational numbers within that range (for e, 2 to 8, 1.5 to 5.5 and 3.1 to 4.7).
This invention may also be said broadly to consist in the parts, elements and
features referred to or indicated in the specification of the application, individually or
collectively, and any or all combinations of any two or more of said parts, elements or
features, and where specific rs are mentioned herein which have known
equivalents in the art to which this invention relates, such known equivalents are deemed
to be incorporated herein as if dually set forth.
The term “comprising” as used in this specification means “consisting at least
in part of”. When interpreting statements in this specification which include that term,
the features, prefaced by that term in each statement, all need to be present but other
features can also be present. Related terms such as “comprise” and “comprised” are to
be interpreted in the same manner.
BRIEF DESCRIPTION OF THE DRAWINGS
The invention will now be described by way of example only and with
reference to the drawings in which:
Figure 1 is a flow diagram showing the processing steps as described.
Figure 2 is a flow m showing the downstream processing steps.
Figure 3 is a graph showing the dry cell weights on days 3, 6, 9, and 12 for
Example 1 referred to in paragraph .
Figure 4 is a graph showing dry cell weights (DCW) for previous flask study
(medium G and J) and this bioreactor study (medium G for GL001-GL003 and medium J
for GL006).
Figure 5 is a graph showing a comparison of total carbohydrate (C)
estimates with the previous study (G and J medium results).
Figure 6 is a graph showing dry cell weights of GL007-GL015 over the
fermentation period.
Figure 7 is a graph showing residual glucose (g/L) present in the supernatant
of GL007-GL015 d during the fermentation period.
Figure 8 is a graph showing estimated PS per dry gram of biomass based on
HPLC peak areas (of target PS) and actual total dry PS.
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to a submerged fermentation process for the
growth of mushroom mycelia, and more particularly a process to provide for one or more
extractable intracellular polysaccharides (IPS).
Submerged fermentation may refer to any tation process where the
reactive components are ed in a liquid phase.
One benefit of the disclosed method may be that the harvested mycelia
exhibited greater IPS content compared to mycelia produced by existing ative
s. Another benefit may be that the speed of mycelia growth is greater relative to
the art. A further benefit may be that the IPS extracted from the a has greater
variance in size relative to the art.
1. Upstream process
The process (as shown in general terms in Figure 1) as described can
y be divided into an upstream and downstream process (shown in Figure 2.) The
upstream process describes the selection of seed through to the production batch. The
downstream process describes collection of the mycelial biomass through to the
tion of polysaccharides.
The present disclosure relates to the fermentation of mushrooms.
The om species may be selected fromInonotus obliquus, Trametes
versicolor, (also known as Coriolus versicolor), ula edodes, Hericium erinaceus,
Cordyceps sinensis, a frondosa, Schizophyllum commune, Flammulina velutipes,
tus ostreatus, Agaricus bisporus, Auricularia auricula, Coprinus comatus, Phellinus
linteus, and Laetiporus reus.
The mushroom species may be selected fromGanoderma lingzhi.
Fermentation is a metabolic s used by many species of bacteria and
fungi. Through the action of enzymes, such species are able to biochemically convert a
given nce into a composite metabolite, thereby releasing energy for use by the
species.
Industry has found utility in different aspects of fermentation. One aspect of
fermentation is that it es a cost effective and sustainable way to convert a given
substance into a given product. This ability has been utilised for instance by the food and
beverage industries to convert precursors into desired consumable products.
Alternatively fermentation may be used as a way to grow desirable bacteria
and fungi. The healthcare and pharmaceutical industry has for ce found many
species of bacteria and fungi to contain useful, cologically active, components.
Therefore, rather than synthetically producing the desired compound, fermentation
provides a more effective pathway to obtain the same result. The given species may be
deliberately grown via fermentation, harvested, and have their useful components
extracted for pharmaceutical commodification.
Mycelium is a subset of fungi that grows via fermentation. Many mycelia
s offer health ts as they contain pharmacologically active IPS. This is robustly
documented across scientific literature, and have been long utilised by many indigenous
cultures.
It is therefore desirable to design a fermentation process that efficiently
grows mycelia with high IPS (intracellular polysaccharide) concentrations. Such a process
may allow the production of mycelia, and the subsequent extraction of socially useful
IPS, on an industrial scale.
There are many variables that may be sed in the design of the ideal
ions for mycelial fermentation. The t method focussed broadly on
submerged fermentation and considers controlling factors such as tation media
(including control of sugar tration), duration of fermentation, stirring, ved
oxygen tration, pH levels, temperature and scale of fermentation.
Through the submerged fermentation s, mycelia are grown from a
seed culture. Therefore, prior to fermentation, a ient quantity of the desired seed
culture must first be obtained.
The seed may be cultured at the beginning of fermentation at about 3.0, 3.5,
4.0, 4.5 or 5.0% v/v, and suitable ranges may be selected from any of these values, for
example the necessary quantity therefore depends on the scale of fermentation.
It will be appreciated that the seed e used may t of a
combination of pre-existing and expanded seed culture. That is, there may initially be an
insufficient quantity of seed culture. A sufficient quantity may therefore be generated by
performing a seed train.
The seed medium may comprise a range of ingredients that support seed
expansion. For example, the seed medium may se a sugar. The sugar may be
present at about 30, 32, 34, 36, 38, 40, 42, 44, 46, 48 or 50 g/L, and suitable ranges
may be selected from any of these values. The sugar may be selected from glucose,
sucrose, maltose, lactose or fructose, or a combination thereof. The seed medium may
comprise a rich nutrient source to support growth. For example, the seed medium may
contain soy peptone, which is high in carbohydrates. The soy peptone may be present at
about 3, 3.2, 3.4, 3.6, 3.8, 4.0, 4.2, 4.4, 4.6, 4.8 or 5.0 g/L, and suitable ranges may be
selected from any of these values. It may also be necessary to include a buffering agent.
The buffering agent may be selected from monopotassium ate. The buffering
agent may be present at about 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9 or 2.0 g/L,
and suitable ranges may be selected from any of these values. The medium may contain
a source of magnesium. The magnesium source may be selected from MgSO4.7H2O. The
magnesium source may be present at 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4 or
1.5 g/L, and suitable ranges may be selected from any of these values.
Mycelial cultures may form pellets when grown in soluble liquid medium,
which creates difficulties for transfer of the expanded seed culture. When this occurs an
insoluble ingredient may be included. This may provide an insoluble matrix to help
diffuse al growth. The media may include about 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5 or
4.0% w/v of an insoluble ingredient, and suitable ranges may be selected from between
any of these values, (for example about 0.5 to about 5, about 0.5 to about 3, about 0.5
to about 2, about 1 to about 4, about 1 to about 3.5, about 1 to about 2.5, about 1 to
about 2, about 1.5 to about 4, about 1.5 to about 3, about 2 to about 4, about 2 to about
3, about 2.5 to about 4, about 2.5 to about 3.5% w/v). Without wishing to be bound by
theory the ble ingredient may assist in keeping the mycelia dispersed. The
insoluble ient may be selected from rice bran. Without g to be bound by
theory, the rice bran may be added to provide an insoluble matrix.
A seed train is a technique that may be used to expand a given culture. At
each stage of the seed train the culture propagates. Seed train stages may be performed
consecutively until the quantity of culture is sufficient for the purposes of the intended
fermentation.
For fermentation procedures performed on an industrial scale, seed
expansion via seed train may be preferred. It is likely more cost ive to purchase
and expand a small quantity of seeds to the ary quantity, rather than regularly
purchase the necessary quantity of seeds.
It may be appreciated that once sufficient seed culture has been prepared,
initiation of the tation process consists of a media being inoculated by the given
seed culture.
Fermentation media is necessary in order to support the growth of the
mycelia. ily the media provides the mycelia with a source of nutrients that can be
metabolically converted into energy. onally, the media may serve further purposes,
for instance pH regulation.
The level of inoculation may be about 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7,
7.5, or 8% v/v, and suitable ranges may be selected from any of these values. (for
example, about 2 to about 8, about 2 to about 7, about 2 to about 6, about 2 to about 4,
about 2.5 to about 8, about 2.5 to about 6.5, about 2.5 to about 4, about 3 to about 8,
about 3 to about 6, about 3 to about 4 or about 4 to about 8 % v/v). For e, a
1,000 L bioreactor may be inoculated with 40 L of secondary seed.
In one embodiment the vessel used for tation is a bioreactor. This
provides the ability to control parameters such as pH, dissolved oxygen, aeration, and
shear force.
The disclosed fermentation process is scalable to an industrial scale.
Therefore, the size of the bioreactor may vary.
The fermentation media in the bioreactor may comprise an anti-foam agent.
The oam agent may be used to reduce any foam that may arise from mycelial
fermentation. The bioreactor may be ed with a foam detector. Upon detecting
foam the detector may dispense oam to counteract the production of foam. An
example of a suitable aming agent includes XIAMETER™ AFE-1520 Antifoam
Emulsion that is a 20% active, food-grade, silicone emulsion. The antifoaming agent may
be dilutable.
The inoculated media may then be fermented for 5, 6, 7, 8, 9, 10, 11 or 12
days. The inoculated media may be fermented for 3, 4, or 5 days. The inoculated media
may periodically be d. The inoculated media may be stirred at about 80, 90, 100,
110, 120, 130, 140, 150 or 160 RPM, and suitable ranges may be selected from between
any of these values, (for example, about 80 to about 160, about 80 to about 150, about
80 to about 110, about 90 to about 160, about 90 to about 150, about 90 to about 120,
about 100 to about 160, about 100 to about 150, about 100 to about 130, about 110 to
about 160, about 110 to about 140 or about 120 to about 160 RPM).
As per the initial stage, once the media is inoculated, the mixture may then
be incubated. The preferred duration may be about 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12
days. The preferred duration may be about 3, 4, or 5 days. The inoculation temperature
may be about 25, 26, 27, 28, 29, 30, 31, 32, 33, 34 or 35° C, and suitable ranges may
be selected from between any of these values. The inoculated media may be stirred at
about 300, 320, 340, 360, 380, 400, 420, 440, 460, 380 or 500 RPM, and suitable
ranges may be selected from between any of these values.
The media may be incubated at about 20, 22, 24, 26, 28, 30, 32, 34, 36, 38
or 40°C, and le ranges may be selected from between any of these values, (for
example, about 20 about 40, about 20 about 36, about 20 about 32, about 20 about 30,
about 22 about 40, about 22 about 36, about 22 about 32, about 24 about 40, about 24
about 38, about 24 about 24, about 26 about 40, about 26 about 38 or about 26 about
32°C).
For seed trains that are intended to grow cultures of theGanoderma genus,
the composition of the preferred media may comprise any one or more of:
30 to 50 g/L glucose,
2 to 6 g/L soy e,
1 to 3 g/L KH2PO4, or
0.5 to 2 g/L MgSO4·7H2O.
The composition of the media may comprise any one or more of about
40 to 60 g/L glucose,
5 to 20 g/L peptone, or
1 to 10 g/L yeast extract.
The media used forGanoderma es may contain a generic sugar, a
generic nutrient source, a generic buffering agent, and a c desiccant.
If the given culture is not a species of theGanoderma genus, it will be
appreciated that the relevant media may be modified to suit that culture.
The media may comprise 30, 35, 40, 45 or 50 g/L glucose (or sugar), and
suitable ranges may be selected from between any of these values, (for example, about
about 50, about 30 about 45, about 30 about 40, about 35 about 50, about 35 about
45, about 35 about 40, about 40 about 50 or about 40 about 45 g/L glucose (or sugar)).
The media may comprise a source of nutrients with a high carbohydrate
t, such as soy e. The media may comprise such a nutrient at about 2, 3, 4,
or 6 g/L, and suitable ranges may be selected from between any of these values, (for
example, about 2 to about 6, about 2 to about 5, about 2 to about 4, about 3 to about 6,
about 3 to about 5, about 3 to about 4 or about 4 to about 6 g/L).
The media may comprise a ing agent, such as KH2PO4. The buffering
agent maybe present at about 1.0, 1.5, 2.0, 2.5 or 3.0 g/L, and suitable ranges may be
selected from between any of these values, (for example, about 1 to about 3, about 1 to
about 2.5, about 1 to about 2, about 1.5 to about 3, about 1.5 to about 2.5 or about 2 to
about 3 g/L).
The media may comprise a magnesium source such as 7H2O. The
magnesium source may be present at 0.5, 1.0, 1.5 or 2 g/L, and le ranges may be
selected from between any of these .
The pH level of the bioreactor may be an important variable with regards to
mycelial growth, as there may be given ranges of pH that are more or less ive to
growth.
In one embodiment the pH may be controlled to be about 3.0, 3.1, 3.2, 3.3,
3.4, 3.5, 3.6, 3.7, 3.8, 3.9, 4.0, 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9 or 5.0, and
suitable ranges may be selected from between any of these values.
The initial stage of fermentation is typically aerobic. Therefore, to ensure
that fermentation can proceed, it may be important to maintain a concentration of
dissolved oxygen in the bioreactor mixture.
The level of lled oxygen may be controlled in the fermentation media.
The level of oxygen in the fermentation mixture may be about 20, 21, 22, 23, 24, 25, 26,
27, 28, 29 or 30%, and suitable ranges may be ed from between any of these
In an alternate ment the levels of dissolved oxygen may not be
controlled.
When conducting biochemical reactions it is generally preferable for the
temperature to be high, in order to maximise the rate of reaction. However, when the
biochemical reaction proceeds via an enzymatic pathway, such as is the case with the
present method, the stability of the enzyme must be considered. Temperature may have
a pronounced effect on enzyme ty; higher temperatures may cause enzymes to
degrade.
In one embodiment the temperature of the fermentation media may be
about 25, 26, 27, 28, 29, 30, 31, 32, 33, 34 or 35° C, and suitable ranges may be
selected from between any of these .
The fermentation mixture may be dosed with sugar during fermentation. The
sugar may be selected from any sugar.
In particular, the sugar used to dose the fermentation mixture may be
selected from glucose, fructose, maltose, sucrose, lactose, galactose, xylose, or a
combination thereof. In particular the sugar is selected from glucose.
Regarding the timing of when the sugar doses are made, it may be
appreciated that the doses may be made between fixed intervals. For instance, it may be
suitable to dose the tation mixture with sugar once a day. The fermentation
mixture may be dosed with sugar at about 15, 20, 25 or 30 g/L and suitable ranges may
be ed from between any of these values.
In an alternate embodiment the timing of each dose of sugar may not be
fixed. It may be desirable to monitor the sugar concentration of the bioreactor, and dose
the mixture with sugar only when the concentration is found to have fallen below a given
threshold. Further, the concentration of the dosage may be variable based on how low
the tration in the ctor has fallen, and what the desired sugar tration
If after any seed train stage there remains an insufficient quantity of seed
culture, a r, successive stage may be performed. A fresh media, of the same
composition as the media used in the preceding stage or stages, may be inoculated by
the expanded seed from the preceding stage. The concentration of the expanded seed
culture relative to the media may preferably be about 2, 3, 4, 5, 6, 7 or 8% by weight,
and suitable ranges may be selected from between any of these values.
The mycelia may attach to surrounding surfaces as they grow. The media
may be subjected to high shear mixing. If the speed of high shear mixing is too fast, it
may damage or break the mycelia. If the speed is too slow, it may be unable to
sufficiently disturb the mycelia and prevent yield loss due to clinging. The red
speed of mixing is about 300, 350, 400, 450, 500, 550 or 600 RPM, and suitable ranges
may be selected from between any of these values.
The shear may be provided by a mixer such as a Rushton turbine or
impeller. A Rushton turbine is an impeller. The impeller may comprise a flat disk with
vertically mounted blades that radially extend from the flat disk. The impeller may
comprise 3, 4, 5, 6, 7, 8, 9, or 10 blades. The tip speed of the distal region of the
impeller should not be so fast as to damage or break the mycelia, nor too slow such that
it does not sufficiently disturb the mycelia and prevent yield loss due to ng. The tip
speed of the impeller may be about 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.4, 2.5,
2.6, 2.7, 2.8, 2.9, 3.0, 3.1, 3.2 or 3.3 m/s, and suitable ranges may be selected from
between any of these values (for example, about 1.5 to about 3.3, about 1.5 to about
3.1, about 1.5 to about 2.9, about 1.5 to about 2.8, about 1.5 to about 2.7 1.5 to about
2.2, about 1.6 to about 3.3, about 1.5 to about 3.1, about 1.5 to about 2.9, about 1.5 to
about 2.8, about 1.5 to about 2.7 1.5 to about 2.2, about 1.7 to about 3.3, about 1.5 to
about 3.1, about 1.5 to about 2.9, about 1.5 to about 2.8, about 1.5 to about 2.7 1.5 to
about 2.2, about 1.8 to about 3.3, about 1.5 to about 3.1, about 1.5 to about 2.9, about
1.5 to about 2.8, about 1.5 to about 2.7 1.5 to about 2.2, about 1.9 to about 3.3, about
1.5 to about 3.1, about 1.5 to about 2.9, about 1.5 to about 2.8, about 1.5 to about 2.7
1.5 to about 2.2, about 2.0 to about 3.3, about 1.5 to about 3.1, about 1.5 to about 2.9,
about 1.5 to about 2.8, about 1.5 to about 2.7 1.5 to about 2.2, about 2.1 to about 3.3,
about 1.5 to about 3.1, about 1.5 to about 2.9, about 1.5 to about 2.8, about 1.5 to
about 2.7 or about 1.5 to about 2.2 m/s). The tip speed may be about 1.8-2.75 m/s.
Prolonged fermentations risk a decrease in the yield of the mycelia upon
harvest. If left to ferment for too long, there may be fruiting body formation (that is,
there is a decrease in the quantity of mycelia because the mycelia is converted into a
fruiting body). Further, the mycelia may cling to the sides of the bioreactor, sing
the quantity of mycelia that can be removed and harvested from the bioreactor at the
end of fermentation.
It may further be able to harvest the mycelia before the point where
the yield begins to decrease due to fruiting and clinging. The rate of al growth
decreases over time. If there are a limited number of bioreactors available for
fermentation, it may be a more ent tion of resources to harvest the mycelia
once the rate of growth falls below a given threshold, thereby allowing the given
bioreactor to be used for a new tation. This maximises the rate of fermentation
across available bioreactors, and hence mycelia production across production facilities.
There is the countervailing concern that by not allowing fermentations to run
their full length, more starting material (media and e) per unit of mycelia produced
is required. Therefore, different durations may be preferred depending on for instance
the cost of starting material versus bioreactor availability and value of harvested mycelia.
and suitable ranges may be selected from n any of these values, (for
example, about 2 to about 6, about 2 to about 5, about 2 to about 4, about 3 to about 6,
about 3 to about 5, about 3 to about 5, about 4 to about 6 or about 4 to about 5 In
one ment the duration of fermentation is three days.
In an alternate embodiment the duration of fermentation may be 2, 3, 4, 5,
or 6 days.
2. Downstream processing
Upon completion of fermentation the grown mycelia may be physically
removed from the bioreactor for downstream processing, culminating in extraction of the
commercially valuable IPS.
In one embodiment the bioreactors are equipped with a nozzle that may be
connected to a hose. When a pressure is applied, the contents of the bioreactor may be
harvested from the bioreactor into a further vessel for downstream processing.
The harvested contents of the bioreactor post-fermentation are a complex
matrix. The d biomass (the mycelia) must therefore be purified from the other
components of the matrix. The first step in tion may be to concentrate the
biomass from the liquid phase.
As a first step, the biomass may be sieved using a 50, 55, 60, 65, 70, 75,
80, 85, 90, 95 or 100 µm sieve, and suitable ranges may be selected from between any
of these values (for example, about 50 to about 100, about 50 to about 90, about 50 to
about 80, about 50 to about 70, about 55 to about 100, about 55 to about 85, about 55
to about 70, about 60 to about 100, about 60 to about 90, about 60 to about 80, about
65 to about 100, about 65 to about 90, about 65 to about 80, about 65 to about 75,
about 70 to about 100, about 70 to about 90, about 70 to about 80, about 70 to about
75 or about 80 to about 100 µm sieve).
The biomass may be concentrated by filtering the harvested contents of the
bioreactor through a hollow fibre membrane (HFM). The pore size of the HFM may be
about 450, 460, 470, 480, 490, 500, 510, 520, 530, 540 or 550 kDa, and suitable ranges
may be ed from between any of these values.
In an alternate embodiment the biomass may be concentrated by rotating
the harvested ts of the bioreactor in a centrifuge.
The process may include a further stage of purification where the liquid
phase separated during the concentration step is used to wash the separated biomass.
The washing may be performed by vacuum filtration, or any alternative technique used in
the ry.
The IPS may be ted from the isolated biomass.
For example, the biomass may first be dried, for example by heating.
The mycelia may first be broken or disrupted. This may assist the better
release and tion of the IPS. The method of mycelia tion may be high shear
overhead mixing, for example, through the use of a Silverson high shear mixer.
The method of mycelia disruption may be high shear homogenisation. For
example, using an emulsion homogeniser such as a microfluiser APVTM. For example, the
biomass may be passed through at about 500, 550, 600, 650, 700, 750, 800, 850, 900,
950 or 1,000 bar, and suitable ranges may be selected from between any of these
values. The biomass may be passed through the emulsion niser multiple times.
For example, the biomass may be passed through the emulsion homogeniser 2, 3, 4, or 5
times, and suitable ranges may be ed from between any of these .
Water may be added to the biomass to assist disruption. That is, water may
be added such that it accounts for 20, 22, 24, 26, 28, 30, 32, 34, 36, 38 or 40% by
weight of the total amount of the biomass (i.e. ing the water), and suitable ranges
may be selected from between any of these values. Without g to be bound by
theory, the addition of water may improve the fluid dynamics in order to assist with
mycelial disruption.
The disrupted mycelia may then be heat treated at about 60, 62, 64, 66, 68,
70, 72, 74, 76, 78, or 80 °C, and suitable ranges may be selected from between any of
these values. The media may then be cooled to about 25, 26, 27, 28, 29, 30, 31, 32, 33,
34 or 35 °C prior to filtration, and suitable ranges may be selected from between any of
these values.
In one embodiment the broken mycelia may be incubated in order to form a
broth. The incubation may make it easier to t the IPS. The fermentation
temperature may be about 25, 26, 27, 28, 29, 30, 31, 32, 33, 34 or 35 °C, and le
ranges may be selected from between any of these values.
The broken mycelia may be filtered to isolate the IPS using a HF membrane.
The pore size of the membrane may be selected from
about 10 kDa,
about 100 kDa, or
about 500 kDa, or
any combination thereof.
In an alternate embodiment any industry filtration technique may be used.
The permeate from filtration may be collected into a tank.
The process may collect IPS having a lar weight of
100-200 kDa,
10-20 kDa, and
1-5 kDa.
The fractions may also compriseα-glucans and β-glucans.
EXAMPLES
A number of different examples are presented that evaluate the mycelia.
Table 1 es a summary of the upstream processing examined, and Table 2
ises the downstream processing that has been examined.
Table 1. Upstream processing examined in Examples 1-5.
Step Media ions Expected
outcomes/QC
checks
Primary seed (4x 2 L 500-mL media: 40.0 Inoculate from DCW (g/L)= 18-20
flasks) g/L glycerol g/L.
glucose, 4.0 g/L soy stock at 2% (v/v). Microscopy for growth
peptone, 1.5 g/L and contamination
KH2PO4, 1.0 g/L 30 °C with 0 check.
MgSO4·7H2O and 2% RPM shaking over 7
(w/v) rice bran. pH days.
adjusted.
Secondary seed 39-L media: 40.0 Inoculate 4% (v/v) DCW g/L of 14-18
(2x 20 L g/L glucose, 4.0 with y seed. g/L. Microscopy for
bioreactors; g/L soy peptone, growth and
Sartorius Biostat 1.5 g/L KH2PO4, Agitation: 400-450 contamination
DCU) and 1.0 g/L RPM (2.17 - 2.45 m/s check.
MgSO4·7H2O. pH tip speed)
not ed.
Aeration: 1
Xiameter 1520 AFE
(0.05 %(v/v in the VVM
media; and as
needed) to control DO and pH
foaming not
controlled
Upto 3
fermentatio
Production batch 960 L medium: 40.0 ate 4% (v/v) DCW of 12-17 g/L.
(1x 1,000 L g/L with
bioreactor; glucose, 10 g/L soy secondary seed. Residual e of 0-
Custom made; peptone, 5 g/L yeast 8
equipped with three extract, 1.5 g/L Agitation: 100-150 g/L.
n impellers, KH2PO4, RPM (1.83 - 2.75 m/s
ring and 0.5 g/L tip speed) Microscopy for growth
r and baffles)
MgSO4·7H2O. pH not and contamination
Aeration: 0.2-1 VVM
adjusted. check.
DO and pH not
Xiameter 1520 AFE Crude PS yield of
controlled. Target
(0.05 % (v/v) in the ~11.5
>30% DO.
media; and as kg
needed)
3-5 days of
to control foaming Purified PS yield of
fermentation ~1.15 kg
~ 6% (w/w) βglucans
in purified PS
Tatua Soy peptone; Food grade glucose (interchem), DSM yeast extract and other
chemicals from Sigma Aldrich
Table 2. Downstream processing steps examined in Examples 1-5.
Step Equipment s ed
outcomes/ QC
checks
Concentration 74 µm sieve and 500 Collect bulk solids Approx 250 kg of bulk
kDa HFM (Koch™ using sieve, scrape solids and 157 kg of
membranes) into a sterile 60-L concentrated biomass
drum. Permeate (retentate).
(from sieving) to be
concentrated using
Disruption Microfluidizer (APV™) Approximately dilute Visualise samples
biomass 1:0.5 on after each pass
weight basis with RO under microscope,
water to improve and t samples
fluid dynamics. Pass for PS and beta
through the glucan analysis.
homogeniser three
times at 600-900
Heat treatment Bioreactor or With low agitation -
temperature (if available),
controlled sterile incubate for 60 min
holding vessel at 70 °C.
Purification 500 kDa HFM Collect Sample for
(Koch™ permeate microscopy and
membranes) (product), and estimation of PS
retentate to content and profiles
waste using HPLC.
Freeze drying Any commercial Freeze dry upto 7 ~11.5 kg of crude
and milling. freeze dryer. Robot days or until PS solids. Pack in
coupe® R45 or constant weight. vacuum sealed
commercial milling Mill to bags.
ent. homogeneity.
1. e 1: Initial flask growth and evaluation of Ganoderma lingzhi
in submerged culture
This example examined the growth ofGanoderma lingzhi in ten different
growth media.
1.1 Method
Shake flasks were harvested on days 3, 6, 9, and 12 and measured for pH
and dry cell .
A subset of the dried mycelial samples was ted in H2O at 70 °C
disruption by sonication, and polysaccharides in the extracts were measured by size
exclusion chromatography (SEC) using high-performance liquid chromatography (HPLC)
and evaporative light scattering detector .
The remaining al samples were extracted in H2O at 70 °C with
sonication, followed by SEC using HPLC and ELSD.
Ganoderma seed medium (GSM) was used to expand the seed culture of G.
lingzhi, and included 40 g/L glucose, 4 g/L soy peptone, 1.5 g/L KH2PO4, and 1 g/L
7H2O. Ground rice bran was included at a rate of 2% (w/v) to provide an
insoluble matrix to support diffuse mycelial growth. A age seed train was used to
expand G. lingzhi. A 250 mL flask containing 50 mL GSM was inoculated with 1 mL of a
glycerol stock vial of G. lingzhi. The flask was incubated at 30 °C with 120 RPM shaking
for 6 days.
The primary seed culture was used to inoculate 500 mL GSM in a 2 L flask at
a rate of 5% (v/v) (25 mL primary seed culture/500 mL GSM). The secondary seed
culture was incubated at 30 °C with 120 RPM shaking for 4 days, at which point there
was thick, e mycelial growth.
Tested production media formulations are shown in Table 3.
Table 3. Formulations, in g/L, of experimental production media
Medium A B C D E F G H I J
glucose 35 25 40 38 50 45 25 20 50
sucrose 20 20
soy peptone 5 5 5 4 4.5 2 10
yeast extract 5 1 2 1 14 14
NH4Cl 4
KH2PO4 1 1.5 0.75 0.5 1 1 1.5 1.5
K2HPO4 0.5
·1H2O 1 2 0.75 0.45
MgSO4·7H2O 0.5 1 1 0.5 0.26 0.26 1 0.5
corn oil 5
The production flasks were inoculated with the secondary seed e at a
rate of 4% (v/v, 2 mL seed culture/50 mL medium). The flasks were incubated at 30 °C,
120 RPM shaking for 12 days. One flask of each medium was harvested completely on
days 3, 6, 9, and 12.
Growth in many of the media was robust by day 3. In some media, there
was little free liquid because s had grown to such high levels.
The pH of each harvested flask was measured. Generally, as aerobic
microorganisms lize carbohydrates (e.g. glucose), organic acids are produced,
which lowers the pH of the e in uncontrolled systems. When available carbohydrate
is exhausted, the culture pH tends to increase. A notable increase in pH was ed by
day 12 in all media except B, E, and F.
To determine dry cell weight (DCW), the entire contents of each harvested
flask were transferred to 50 mL centrifuge tubes and centrifuged at 4700 RPM (4816 g)
for 20 min. The supernatant was removed, and the pellets were washed with up to 20 mL
phosphate buffered saline to remove residual medium. The washed biomass was
centrifuged again at 4700 RPM for 20 min, and the supernatant was removed. The tubes
were placed, uncapped, in a 70° C drying oven for 3 days to dry the biomass to
completion. Based on resulting dry pellet, DCW was calculated. The results are shown in
Figure 3.
Extraction and polysaccharide analysis
Extraction of dried mycelial biomass was conducted on all samples. The
mycelial s was subjected only to aqueous extraction conditions. Reverse osmosis
(RO) H2O was added to each sample at a ratio of 1:10 dried biomass:RO H2O. All
extractions were d out in a shaking water bath at 70 °C with 200 RPM linear
agitation. Samples were extracted twice with RO H2O for 2 h each. After the first
extraction, the mixture was centrifuged at 4000 RPM (3488 g) for 5 min. The
supernatant was removed, and an equal volume of RO H2O was ed to the biomass
for the second extraction. The supernatant from the second extraction was added to the
first extract, and the combined extract was filtered across a 0.2 µm membrane to ensure
no viable G. lingzhi material remained.
Extracts were subjected to size exclusion chromatography (SEC) using rformance
liquid chromatography (HPLC) and evaporative light scattering detector
(ELSD) to assess the polysaccharide profiles of each sample.
1.2 Results
As shown in Table 4 three groups of peaks were observed in the mycelial
extracts: early which are t to be higher MW polysaccharides produced during
fermentation; middle which are t to be mainly associated with monomers and
other media components; and late, which are unknown compounds. The areas of the
peaks in each of these sections were calculated by integrating the area under the peaks.
Table 4: Early (A), middle (B), and late (C) peaks observed in the mycelial ts. Table
2. Early, middle, and late peak areas of each extract.
Day 3 Day 6 Day 9 Day 12
Medium Early Middle Late Early Middle Late Early Middle Late Early Middle Late
A 26.4 23.7 17.5 6.6 4.9 4.8 8.5 1.3 7.3 8.7 1.7 7.1
B 14.4 25.0 13.3 11.7 10.8 10.2 14.7 11.9 12.3 17.6 10.1 14.6
C 8.5 6.8 6.6 6.0 11.5 5.9 7.6 0.8 7.4 8.3 1.5 7.9
D 11.2 13.8 6.7 6.3 10.4 5.0 5.0 5.7 3.1 7.4 0.5 6.6
E 12.2 17.4 7.9 6.4 9.8 5.3 10.9 12.8 10.3 6.4 7.3 6.0
F 11.1 15.1 7.5 10.6 9.2 8.6 5.9 4.7 4.7 6.3 5.8 4.8
G 11.4 10.9 5.6 7.3 8.0 4.1 6.6 2.5 4.1 7.1 2.4 4.5
H 12.0 27.4 6.7 7.1 10.0 5.4 12.4 12.1 9.2 9.4 12.2 6.7
I 9.8 13.8 8.2 10.5 11.6 10.0 12.3 0.6 11.9 10.0 0.3 10.2
J 12.5 14.2 6.2 8.2 22.3 4.6 7.7 10.8 7.0 6.3 4.0 4.5
The best growth was observed in media G and J, which both achieved final
DCWs of ca. 26 g/L on day 12.
2. Example 2: Scale-up of Ganoderma lingzhi growth in submerged culture
This e looked at the growth ofGanoderma in 1 L bioreactors.
Two media and three process conditions were evaluated in 1 L bioreactors
for growth and intracellular polysaccharide production by rma lingzhi. The process
conditions include
a pH/dissolved oxygen (DO) shift,
constant pH, and
continuous fed-batch additions of glucose.
Two stage seed cultures were made in flasks, and a 3% v/v inoculation rate
was used for the bioreactors.
Experiments in six bioreactors were run for 12 days, and were periodically
sampled at 3, 6, 9 and 12 days.
Samples were analysed for dry cell s (DCW) to assess growth, and
both wet and dry extracts were used for SEC HPLC and total carbohydrate analysis as per
methods developed in us s.
2.1 Methods
Ganodermaseed medium (GSM) was used to expand the seed e of G.
lingzhi, and included, 40 g/L glucose, 4 g/L soy peptone, 1.5 g/L , and 1 g/L
MgSO4·7H2O. Ground rice bran was included at a rate of 2% (w/v) to provide an
ble matrix to help diffuse mycelial growth. A two-stage seed train was used to
expand G. lingzhi. Primary (1°) seed was prepared by inoculating 2 mL vial in 100 mL
(2%, v/v) of GSM and incubated for 8 days at 30 °C and 120 rpm. Secondary (2°) seed
was prepared by inoculating 12 mL of 1° seed in 300 mL GSM (4 %, v/v) and incubating
for 7 days at 30 °C and 140 rpm.
Two media recipes and three conditions in each were assessed for the
growth and polysaccharide production in 1 L reactors over the period of 12 days (see
Table 5). Production media (G and J) was prepared in bulk, and aliquoted into
bioreactors. The reactors were then sterilised for 20 min at 121 °C and 15 psi. A 3%
(v/v) inoculation was made. Samples were taken at four points (Days 3, 6, 9 and 12) for
analysis. Temperature was maintained at 30 °C, and pH was controlled with manual
additions of 1 M H3PO4 and 1 M NaOH. Xiameter 1520 AFE (0.05%) was added directly to
the media for controlling foaming. Experimental conditions are shown below in Table 5.
Two 50 mL samples were pulled out at each point into tared 50 mL Falcon
tubes. The weight of the culture was measured and then the samples were spun at 4,700
RPM for 20 min. The supernatant was discarded, and the pellet was washed twice with
PBS (pH 7.4). One tube was stored at 4 °C to be used for wet extraction, and the other
was dried at 60 °C for 3 days for dry extraction.
Table 5. Growth media and reactor conditions trialled
Run ID (1 L
Conditions
bioreactors)
pH lled at 3 (Days 0-4); pH at 4.5 (until harvest)
GL001 DO controlled at ≥25% (Days 0-6); DO at 10% (until harvest)
Constant pH at 4-4.5 throughout the run. DO not controlled.
GL002
Agitation at 400 RPM. Aeration at 1 LPM.
Repeated fed-batch addition of glucose (20 g/L). pH and DO
GL003
not controlled. Agitation at 400 RPM. Aeration at 1 LPM.
pH controlled at 3 (Days 0-4); pH at 4.5 (until harvest)
GL004
DO lled at ≥25% (Days 0-6); DO at 10% (until harvest)
Constant pH at 4-4.5 throughout the run. DO not controlled.
GL005
ion at 400 RPM. Aeration at 1 LPM.
Repeated fed-batch addition of glucose (20 g/L). pH and DO not
GL006
lled. Agitation at 400 RPM. Aeration at 1 LPM.
All fermentations ran for 12 days. The dry cell s (DCW) are shown in
Figure 4, also a comparison with media G and J from Example 1 is shown. As the run
progressed there was formation of fruiting bodies in the bioreactor, particularly in
bioreactors with Medium G (GL001 – GL003), therefore the sampled volume is not
representative of the total biomass, rather the submerged biomass. Formation of fruiting
bodies could be a factor of pH, dissolved oxygen or tip speed. r, it was noted that
the rice bran was not added to the media in reactors, which could have helped restrict
the formation of fruiting bodies (as seen in flasks). Despite this, fewer fruiting bodies
were seen in GL005, indicating that the medium and process ters such as pH
(4.5) and ved oxygen could also contribute to better submerged growth.
Glucose (20 g/L) was added on Day 3 for cultures GL003, as the pH dipped
to ~ 3.4. Glucose bolus seems to have positive effect as seen in Day 6 DCW of the
culture GL005.
Extraction and polysaccharide analysis
Intracellular polysaccharides were extracted from dry cell pellets using the
extraction method described in e 1. A modified protocol was used for extraction
from wet cell pellets. The total samples for extraction was 44 and the final filtered
s of extracts ranged from 0.3 ml to 15 mL.
Dry cell extraction
Dry cell pellet weight was determined and reverse osmosis (RO) H2O added
to each sample at a ratio of 1:10 dried biomass:RO H2O. A minimum volume of 500 µL
was used. The s were incubated at 70 °C with 200 RPM linear agitation for 1 h.
The samples were ted in a sonication water bath at 65 °C for 30 min, then
returned to the shaking water bath for 1 h. The s were centrifuged at 4,700 RPM
for 5 min, and the supernatant transferred to a fresh tube. A second extraction was
performed by adding the same volume of RO H2O and ting for 2 h at 70 °C with
200 RPM linear agitation. The samples were centrifuged at 4,700 RPM for 5 min, and the
supernatant combined with the first extraction. The extracts were filtered across a 0.2
µm membrane to remove viable G. i material.
Wet cell extraction
The same volume of RO H2O used for dry cell extraction was added to the
wet cell pellets. The cells were disrupted by homogenization at 13,500 RPM for 1 min.
The samples were incubated at 70 °C with 200 RPM linear agitation for 2 h. The samples
were centrifuged at 4,700 RPM for 5 min, and the supernatant transferred to a fresh
tube. A second extraction was med by adding the same volume of RO H2O and
incubating for 2 h at 70 °C with 200 RPM linear agitation. The samples were centrifuged
at 4,700 RPM for 5 min, and the supernatant combine with the first extraction. The
extracts were filtered across a 0.2 µm ne to remove viable G. lingzhi material.
SEC HPLC polysaccharide analysis
Samples of filtered extracts were provided for each of 6 cultures (GL001
through to GL006) with individual samples at days 3, 6, 9 and 12. Only day 3 and 6
samples were collected for GL005.
s were either from “dry” extraction or “wet” extraction for a total of
44 samples. Samples were analysed directly as described previously for SEC HPLC
chromatography.
2.2 Results
Early peaks indicate high molecular weight compounds, mid-peak may be
monosaccharides or media components and late peak are unknown compounds. None of
the cultures appear to be producing significant quantities of high MW carbohydrates
which would appear as broad peaks around the early peak area in the chromatogram.
Figure 5 shows that both GL005 and GL006 had higher total carbohydrates
when compared to the us study of Example 1.
Total carbohydrate analysis.
The total carbohydrate analysis was performed using the phenol ric
acid colorimetric analysis method as bed earlier. Samples were diluted 1 in 16 with
led water. The results are shown in Table 6.
Table 6. Total carbohydrates as mg/ml glucose in WET and DRY ts
Measurement Glucose (mg/mL)
Sample Day Wet extract Dry extract
GL001 3 2.7 1.6
6 1.9 9.9
9 4.7 15.4
12 13.5 7.4
GL002 3 12.7 24.4
6 1.3 1.8
9 1.2 2.1
12 3.9 1.5
GL003 3 11.2 11.3
6 3.8 6.1
9 3.1 6.2
12 1.8 1.2
GL004 3 10 13.1
6 9.3 18.5
9 2 13.4
12 3.5 9.6
GL005 3 12.1 15.8
6 23 16.5
GL006 3 11 12.3
6 19.9 18.1
9 14.2 18.2
12 9.4 16
G. lingzhishowed good submerged growth in the bioreactors with Medium J.
G. lingzhi grew well as a submerged culture at pH 4.5 when ed to the pH at 3.0.
The extracts were analysed by SEC HPLC to obtain fingerprint profiles of MW
distribution as well as total carbohydrate analysis. The total carbohydrates as determined
from total peak area in SEC HPLC and the colorimetric method appear to be in reasonable
agreement. There is a higher level of total carbohydrates in the dry extracts, e.g. GL004
Wet extract –day 12 has 3.5 vs GL004 Dry extract- day 12 at 9.6 mg/mL. Otherwise the
wet and dry extracts are somewhat similar in terms of changes through the fermentation
period.
GL005 and GL006 appear to give an increase or relatively constant level of
carbohydrates throughout the tation period and were higher than that seen in
Medium J of Example 1.
3. Example 3: Bioreactor fermentations at 1 L scale
The e examined a set of nine fermentation runs over two batches
(Stage 1 and 2) to study the impact of s process conditions on submerged growth
and polysaccharides (IPS) formation. Stage 1 fermentations were run for 10 days, and
Stage 2 for 6-days. The fermentation period was reduced in order to limit fruiting body
formation.
In summary, the process conditions studied were aeration (0.5-1
litres/minute [LMP]), agitation (200-400 RPM), repeated glucose addition (to keep
residual glucose levels 20-30 g/L, where practically possible), with and without pH
control and DO control.
All fermentations were run sfully, and targets of higher submerged
biomass and PS profiles were successfully ed.
GL008, GL012 and GL014 produced highest dry cell weights (DCW) of 18,
21 and 14 g/L, respectively. These values were higher than those reported
in Example 2.
All the fermentations showed submerged growth initially (except GL007),
however due to the body ion, the submerged growth decreased over
the fermentation period.
The submerged biomass, atant and fruiting bodies were analysed for
PS profile ination using SEC HPLC. β-glucan analysis was performed
on the AG standard extract and the GL014 biomass and extract (Day 3 and
6 sampled combined).
o All the fermentations (especially, GL008, GL011, GL012 and GL014)
had similar profiles to that of AG rd (extract from AG fruiting
bodies from China), however, the quantity of the PS varied amongst
the fermentations.
o Supernatants and fruiting bodies had little to no target PS, confirming
that the mycelial biomass retains most of the PS.
o Molecular weight determination using MALLS indicated that the
submerged fermentations had similar molar mass of PS as seen in AG
standard (5 KDa).
o Highest PS t was seen in GL014 followed by GL011 and GL008.
o Biomass and extracts samples from GL014 (Day 3 and 6) had 12.36%
and 5.24% of β-glucans, when compared to 11.73% in the Standard
extract.
Methods
“Ganoderma seed ” (GSM) was used to expand the seed culture of G.
lingzhi, and ed, 40 g/L glucose, 4 g/L soy peptone, 1.5 g/L KH2PO4, and 1 g/L
MgSO4·7H2O. Ground rice bran was included at a rate of 2% (w/v) to provide an insoluble
matrix to help diffuse mycelial growth. A two-stage seed train was used to expand G.
lingzhi. Primary (1°) seed was prepared by inoculating 2 mL vial in 100 mL (2%, v/v) of
GSM and incubated for 7 days at 30 °C and 120 rpm. Secondary (2°) seed was prepared
by inoculating 12 mL of 1° seed in 300 mL GSM (4 %, v/v) and ting for 7 days at
°C and 140 rpm. Secondary seed had a DCW of 18.8 g/L.
Experimental setup in 1 L ctors
Medium J was prepared and sterilized as described in Example 1. Rice bran
was not added to the reactors. A total of nine conditions were studied and the
experimental conditions are ted in Table 7.
Table 7. Experimental conditions studied (GL007-GL015)
Run# Details Notes
Stage 1 (10 days – fermentation)
GL007 Constant pH (4-4.5); No DO control; 400 rpm; 1 Repetition of GL005 (SOW2a)
GL008 Repeated glucose addition; No pH and DO control; tion of GL006 )
400 rpm; 1 LPM
GL009 Repeated glucose addition; Constant pH (4-4.5); Same as GL012 but with pH and DO
Do control (>25% for 6 days; <10% until harvest) control
GL010 Constant pH (4-4.5); DO control (>25% for 6 days; Same as GL007 but with DO control
<10% until harvest)
GL011 Constant pH (4-4.5); No DO control; 100-200 rpm; Same as GL007, but with lower
1 LPM. agitation
GL012 Repeated glucose addition; No pH and DO control; Same as GL008, but with lower
100-200 rpm; 1 LPM agitation
Stage 2 (6 days – fermentation)
GL013 Repeated glucose on; No pH and DO control; Same as GL008 but with lower
400 rpm; 0.5 LPM aeration rate
GL014 Constant pH (4-4.5); No DO l; 100-200 rpm; Same as GL011 but with lower
0.5 LPM. aeration rate
GL015 Constant pH (4-4.5); One-off glucose bolus (on Same as GL011 but with DO control
Day 3), DO control (3 days - >25%; Until harvest (3 days - >25%; Until harvest <10%)
<10%) Agitation and Aeration in cascade (50-400
rpm, 0.1-1 LPM)
A 5% (v/v) ation was added to the reactors from the secondary seed.
Stage 1 fermentations were run for 10 days, whereas stage 2 fermentations for 6 days.
Prolonged fermentations were avoided to limit fruiting body formation. The runs were
periodically sampled for dry cell weight (DCW), residual glucose concentrations and
polysaccharide (PS) analysis of both the biomass and supernatants. Fruiting bodies were
collected at the end of the run and were analyzed for DCW and PS analysis. Sterile bolus
of glucose was added to GL008, GL009, GL012 and GL013 to keep the glucose levels 20-
g/L. In addition, one-off glucose bolus was added to GL015, before ng the DO
control to ≤10% on Day-3.
3.1 s
All fermentations were run successfully. DCW for GL007-GL015 is presented
in Figure 6.
By Day-3, the DCW of all fermentations was >4 g/L, except for GL009. By
Day-6, the DCW of GL008, GL009, GL011 and GL012 more than doubled. Amongst the
stage 2 fermentations, GL013 produced 13 g/L DCW by Day 6, whereas the DCW
decreased to 3.59 g/L from 9.68 g/L (Day 3) in GL013; and decreased to 4.21 g/L from
7.79 g/L (Day 3) in GL015. Similar decrease in DCW was also evident in GL007, GL009,
GL010 and GL011. By the end of tations (Day 10 for stage 1 and Day 6 for stage
2), GL008, GL012 and GL014 produced highest DCW of 18.1 g/L, 20.8 g/L and 13.1 g/L,
tively.
Residual glucose (g/L) in GL015 is shown in Figure 7. Except where
glucose bolus was added and in GL014, the residual glucose was ~0 g/L by Day 6
indicating the complete exhaustion of the readily available C source.
All parameters were controlled as per the experimental plan. AFE Xiameter
was added to control the foaming as required (foaming was more evident at the start of
the runs). 1M NaOH and 1M H3PO4 was lly used to control pH in Stage 1
fermentations (GL007, GL009, GL010 and GL011). However, due to utilization of
excessive s of both acid and base by GL007 and GL010, the acid and base was
upgraded to 5M NaOH and 5M H3PO4 on Day 2 for all the reactors (with pH control
conditions). For stage 2 fermentations, 5M acid and base was used from the beginning.
Overall, the fruiting bodies were less t in GL008, GL011, GL012 and
GL015. GL015 produced the least amount of fruiting bodies.
Extraction, polysaccharide and β-glucan analysis:
Intracellular polysaccharides were extracted from dry and wet cell pellets
using the extraction method described in Example 2. For the HPLC profiles, samples are
labelled in the following manner: 7W-day3 = Fermentation GL007, wet t from day
three).
SEC HPLC polysaccharide is
Samples of filtered extracts were ed for each of 6 cultures (GL007
through to GL012) with individual samples at days 3, 6, and 10. Only day 3 and 6
samples were collected for -15. Only dry extraction samples were analyzed
directly as described previously for SEC HPLC chromatography.
is was initially performed on all samples as described earlier using SEC
HPLC. This method used the provided samples directly for analysis.
However, work on selected samples using lar weight cut-off filters
(MWCO) showed that a ccharide concentration step was necessary to enhance the
polysaccharide concentration in each sample prior to analysis. The biomass and
supernatant polysaccharides were concentrated using ethanol precipitation. Briefly the
method used: 2 ml of sample was taken, and 8 ml of abs. ethanol was added, the sample
shaken and fuged, the pellet was re-suspended in 0.5 ml water. After sonication
and centrifugation, the resultant supernatant was used directly for analysis.
s from SEC HPLC of polysaccharide concentrates of samples.
In general, all samples showed a broad polysaccharide peak as described
above, some samples also showed significant large peaks at 10 minutes.
There was a lot of rity between the biomass extracts and the standard
material.
The estimated PS content was calculated based on the peak area, converting
to µg polysaccharide using a standard curve for standard, then converted to mg/g
biomass based on weight of biomass.
Using the above standard curve, the estimated PS data for all the
fermentations is shown in Table 8 and Table 9. Table 8 is the estimated PS content per
gram of dry biomass, s Table 9 is the estimated PS content per total dry biomass
produced in a 1 L fermentation broth.
Table 8. Estimated PS content per dry gram of biomass. The values are based on the
peak areas obtained from SEC HPLC
Sample Mg Polysaccharide
Day 3 Day 6 Day 10
GL007 90.3 76.6 0.0
GL008 63.0 40.0 35.2
GL009 76.8 40.1 0.0
GL010 75.9 70.7 62.3
GL011 89.5 71.8 53.5
GL012 80.1 31.6 24.9
GL013 51.7 69.9
GL014 90.3 91.1
GL015 70.3 109.0
Table 9. Estimated PS content per total dry biomass produced per litre of fermentation.
The values are based on the peak areas ed from SEC HPLC
Sample Mg Polysaccharide
Day 3 Day 6 Day 10
GL007 361.1 191.4 0.0
GL008 377.8 559.5 633.5
GL009 153.6 200.6 0.0
GL010 531.0 494.9 218.2
GL011 402.5 646.0 213.8
GL012 376.7 474.4 523.6
GL013 500.1 251.4
GL014 828.6 1194.7
GL015 548.1 459.7
The total PS content in a litre of fermentation indicates that GL014 produced
up to 1,200 mg of PS, followed by GL011 and GL008.
Analysis of fruiting bodies and supernatant
Each of these samples from Day 10 was treated to produce a polysaccharide
concentrate as described previously. Almost all of the supernatants and fruiting bodies
have high levels of peaks ascribed to lower MW ccharides or non-polysaccharide
material (Table 8 and Table 9). Therefore, it is suggested that the Figures for PS content
from the peak areas are not comparable with the s extract numbers. The two
exceptions are the fruiting bodies from 8 and 12 which show more typical polysaccharide
type analytical profiles (Table 8). This trates that the fruiting bodies and
supernatants have no or very little polysaccharides.
Molecular weight determination using MALLS
The molecular weight was determined using the Multiangle laser light
scattering (MALLS) detection system to confirm the similarity n the AG standard
sample and the submerged fermentation samples. Only GL014 and GL015 was run for
confirmation. s indicate that the molar mass distribution of GL014 Day 6 and
GL015 Day 6 samples were 4.7 KDa and 7.5 KDa respectively.
Determination of total β-glucan content
an analysis was carried out on GL014 by pooling Day 3 and 6 samples.
The totalβ-glucan t was determined using the Megazyme assay kit
based on the method by McCleary and Draga following the instruction given in the
manual. This assay is based on the determination of the total glucan t and the αglucan
content. The an content is then calculated by subtracting the α-glucan
content from the total glucan content.
Briefly, for the determination of the total glucan content the samples (90
mg) were treated with 2 mL ice cold sulphuric acid (12 M) on an ice water bath for 2 h
with occasional vigorous stirring on a vortex mixer. After addition of 4 mL water, the
contents were vigorously mixed on a vortex mixer and another 6 mL water was added
followed by mixing. The samples were heated at 100 °C for 2 h. After cooling down, the
samples were transferred into 100-mL measuring flasks, 6 mL KOH (10 M) were added
and the volume was made up to 100 mL with acetate buffer (200 mM). An aliquot of the
on was centrifuged at 1500 g for 10 minutes. The amount of glucose released from
both α and β-glucans was determined by treating 100 µL sample solution with 100 µL
enzyme mixture (containing exo-glucanase (20 U/mL) and β-glucosidase (4 U/mL)) at
40 °C for 1 h. To the reaction e was added 3 mL of GOPOD reagent (mixture of
glucose e plus peroxidase and 4-aminoentipyrine in pH 7.4 buffer) and allowed to
incubate for 20 min at 40 °C. 200 µL aliquots were transferred to a microtiter plate well
and the absorption at 510 nm was determined against the reagent blank.
For the determination of theα-glucan content, the samples (100 mg) were
treated with 2 mL KOH (2 M) for 20 minutes on ice followed by the addition of 8 mL of
1.2 M acetate buffer (pH 3.8). After addition of200 µL of enzyme (amyloglucosidase
(1,630 U/mL) and invertase (500 U/mL)) the samples were incubated at 40 °C for 30
s. The volume was made up to 100 mL and an aliquot of the resulting solution was
fuged 1500 g for 10 minutes. The amount of ed glucose was determined as
described above. The amount of β-glucan content was determined by cting the
amount of α- glucan from the total glucan content. All samples were investigated in
triplicates.
Both the extract obtained from the biomass and the biomass itself were
tested for their β-glucan content as described under methods. As a control, a standard
supplied by α-group was subjected to the analysis protocol. The s are ised
in Table 2
Table 10. Determination of the β-glucan content in the AG standard and GL014 samples
using the me assay kit
Sample % total glucan % -glucan % β-glucan
Standard control extract 12.31 ± 2.82 0.76 ± 0.03 11.73 ± 2.54
Extract from GL014 (day 3 and 6 5.53 ± 0.26 0.35 ± 0.12 5.24 ± 0.35
combined)
Biomass from GL014 (day 3 and 6 20.3 ± 1.07 8.47 ± 1.84 12.36 ± 1.65
combined)
The total glucan t in the combined biomass generated during the
fermentation process is 20.3% with an approximate ratio of β- to α-glucan 3:2. In
comparison, the content of total glucan in the extract from this material is much lower
(5.53%). However, the ratio between β- and α-glucan has increased with most of the
glucan comprising an (approximately 95%) and is comparable to the ratio found
for the standard control extract provided by the α-group.
In summary, all fermentations were run successfully. Compared to previous
runs, ng bodies formation was limited. GL008, GL012 and GL014 showed highest
submerged growth so far in the 1L bioreactors (18, 21 and 13 g/L, respectively). The
fermentation period can be reduced to 6-days to avoid fruiting body formation. Agitation
(400 rpm), aeration (0.5-1 LPM), No pH and DO control and repeated e addition
tends to support better submerged growth
4. Example 4: Scale-up in two 20 L bioreactors
The fermentation process was scaled up in 2 x 20 L bioreactors to validate
the conditions developed in previous 1 L batch – GL027, and to develop large scale
downstream process ions.
Seeds were expanded over two stages in flasks. Secondary seed reached a
dry cell weight (DCW) of 17 g/L after four days of incubation at 30 °C and 140 RPM.
Two 20 L bioreactors (GL028 and GL029) were SIP (sterilised in place) and
inoculated with 4% (v/v) of secondary seed. Anti-foam l was kept on auto.
Dissolved oxygen (DO) and pH were not controlled. Concentrated glucose (500 g/L) was
added at a rate of 20 g/L on Days 1, 2, 3 and 4 of fermentation.
4.1 Methods and results
Fermentations were carried out in 2 x 20-L parallel bioreactors for five days
and biomass was concentrated using 500 kDa HFM pilot plant. Representative portions of
trated biomass (~0.8 kg) were used to trial with different tion experiments
(GLLSE-01, GLLSE-02 and GLLSE-03) to assess the efficiency of extraction.
Fermentation process
Ganoderma seed medium (GSM) was used to expand the seed culture ofG.
lingzhi, and ed, 40 g/L glucose, 4 g/L soy peptone, 1.5 g/L KH2PO4, and 1 g/L
MgSO4·7H2O. Ground rice bran was included at a rate of 2% (w/v) to provide an insoluble
matrix to help diffuse mycelial growth. A age seed train was used to expand G.
i. Primary (1°) seed was prepared by inoculating 2 mL vial in 100 mL (2%, v/v) of
GSM and incubated for 7 days at 30 °C and 120 RPM. Secondary (2°) seed was ed
by inoculating 16 mL of 1° seed in four 400 mL GSM (4 %, v/v) and incubating for 4 days
at 30 °C and 140 RPM. The cultures from two secondary flasks each were combined and
used for inoculating GL028 and GL029.
Fermentation process and media conditions were run in duplicates.
Fermentation was carried out for five days with fed-batch glucose dosing (20 g/L) on
Days 1, 2, 3 and 4. A concentrated glucose solution (500 g/L) was used for dosing.
The pH profile from this study is also similar to the previous 1 L batch
(GL027), suggesting that the s did not behave differently when scaled-up.
Table 11. Fermentation Conditions studied over Stage 3 and 4 fermentation batches
L batch# s Seed conditions
Similar to GLO27 (SOW3 Stage 4). Similar to GL027.
High aeration (400 RPM) and agitation (1 VVM), Two stage; Primary seed
GL028 and GL029
ed batch medium (glucose-50 g/L, peptone- and secondary seeds
(Duplicates)
g/L and yeast extract-5 g/L). Fed-batch glucose grown for 7 and 4 days,
(20 g/L/day) respectively.
Duplicate 50 mL s of submerged biomass were taken on Days 1, 2, 3,
4 and 5 and were centrifuged and dried in oven at 60 °C for 3-4 days to te dry cell
weights (DCW) in g/L (Table 12).
Table 12. DCW of GL028 and GL029 during days 1-5, and the combined concentrate from
GL028 and GL029. Day-5 DCW data point from previous study in 1 L bioreactor – GL027
(Example 3) is also ed for comparison
Sample DCW g/L
Day 1 Day 2 Day 3 Day 4 Day 5
GL028 10.0±0.73 26.1±0.14 .40 21.0±0.13 28.5±0.87
GL029 10.1±0.32 22.9±0.35 16.5±0.50 19.2±0.46 18.5±0.76
The DCW (g/L) for GL028 and GL029 are shown in Table 12. Error is given as
standard deviation. For comparison, the Day 5 DCW of previous 1 L batch (GL027) was
.6 and a concentrate as 29.5±0.34. After Day 1, the DCW of both GL028 and
GL029 were similar and low at ~10 g/L; an increase in biomass was seen from Day 2.
High DCW of 26 g/L and 28 g/L were evident for GL028 on Days 2 and 5, tively;
whereas highest DCW (22 g/L) for GL029 was evident on Day 2 and then the DCW
decreased by Day 5. Since the pH and DO profiles were similar for both batches, the
difference in DCW may be attributed to the insoluble mycelia. In addition, more attached
mycelia were found in GL029 compared to GL028, which further supports justification of
the deviation. These mycelia were referred to as fruiting bodies in the previous s,
r they are best to be described as insoluble mycelia attached to the surfaces.
Regardless, high DCW were evident in 20 L batches (average of 26 g/L) compared to the
previous 1 L batch (15 g/L), ting that the process scaled-up successfully in terms
of submerged biomass yield.
Due to technical issues, the residual glucose was not calculated during the
fermentation, however Day 1-5 samples for both GL028 and GL029 were analyzed using
HPLC at later stage.
Table 13. Residual glucose concentrations as measured by HPLC during the five-day
fermentation period of GL028 and GL029. * indicates, fed-batch addition of glucose (20
g/L) was after sampling.
Sample Residual glucose g/L
Day 1 Day 2 Day 3 Day 4 Day 5
GL028 25.3 35.8 38.1 46.8 52.9
GL029 33 36.5 42.7 60.4 55.5
The glucose concentrations were between 25-60 g/L during the
fermentation. In contrast, the al glucose for the previous 1 L batch (GL027) was
consistently 0 g/L during days 2-5.
Downstream process
About 38 kg was ted and combined from both 20 L batches (GL028 and
GL029) and concentrated using pilot scale 500 kDa HFM plant. About 32.75 L of permeate
(equivalent to supernatant) was collected and only 2.25 kg of retentate (concentrated
biomass) was collected. An additional 3 L of the collected permeate was used to wash the
ate line of the HFM which resulted in a total ted concentrated biomass of 5.25
kg. A portion of the estimated biomass (~3 kg) could not be collected, due to the
difficulties with processing low s using a pilot HFM plant. This challenge can be
overcome by simply washing the membrane filter with phosphate buffer saline (PBS). The
concentration step can be re- validated in the next stage of scale-up.
Representative samples of the concentrate were taken to estimate DCW and
ccharide (PS) analysis using previously established analytical ques. The rest
of the concentrated biomass was aliquoted into ~0.8 kg batches and stored at -20 °C for
extraction experiments.
Three extraction experiments were carried out (Batches: GLLSE-01, -02 and
-03). In contrast to the previous analytical methods, drying of biomass postconcentration
was not carried out for these three extraction experiments. To break the
mycelia, Silverson™ high shear ad mixer was used for 30 min for two ments
(GLLSE-01 and GLLSE-02), and a high shear homogeniser (APV ™) was used for the third
experiment (GLLSE-03), where three passes at 600 bar pressure was used to disrupt the
mycelia. Both experiments using the Silverson high shear mixer, (GLLSE-01 and GLLSE -
02) were similar except that the biomass was washed before extraction for GLLSE-02
batch. Each 0.8 kg biomass batch was thawed and extracted either using Silverson mixer
or homogeniser and incubated at 70 °C for 1 hr to allow polysaccharides to dissolve in
the broth. The extracts were then ed using 500 kDa and 100 kDa HFM. Further
tion up to 10 kDa was carried out for GLLSE-03 to compare the PS profile.
Samples from each fraction were analysed for PS (profile and yields), beta glucans,
triterpenes and MALLS (to estimate the size of the PS).
Polysaccharide and β-glucan analysis
Previous work on selected samples using molecular weight cut-off filters
(MWCO) showed that a polysaccharide concentration step was necessary to enhance the
polysaccharide concentration in each sample prior to analysis. However, this may not be
required during the cturing process. The s used for PS is were as
described in the previous reports. y, the method used: 2 mL of sample was taken,
and 8 mL of absolute ethanol was added, the sample shaken and centrifuged, the pellet
was re-suspended in 0.5 mL water. After sonication and centrifugation, the resultant
supernatant was used directly for is.
A standard curve was prepared using a sample of the rd
ccharide at 10 mg/mL. The GL028 and GL029 s show similar profiles, a
large peak at ca. 10 min is more obvious in the Day 1 samples than Day 5. The profiles
of all extracts are somewhat different from the standard in showing a broad peak
(“hump”) centered around 8 min, this may be due to higher levels of slightly larger
polysaccharide than the Standard extract. There was no obvious difference between the
membrane samples from GLLSE- 01 to -03 experiments, except that the 500 kDa and
100 kDa fractions from GLLSE-03 had spikes of peak ca. 7 min. Also, overall peak areas
were larger than other samples indicting that more of the PS was ted using the
homogenizer.
Figure 8 shows PS yields of both estimated based on HPLC peak areas (6-11
min) and total dry PS solids per gram of dry biomass. It is important to note that for
some samples (GLLSE-02) the actual yield of “solids PS” after freeze drying is only
around half the value estimated from the rd curve using the AG standard. The AG
standard does not all dissolve in water leading to over estimation of PS, and the PS
response will vary ing to molecular weight.
Estimated PS for analytical samples of both GL028 and GL029 varied during
the five-day fermentation period. Day 3 tends to accumulate higher estimated PS per dry
g biomass. Interestingly, the 100 kDa fractions of GLLSE-03 is more than two-fold when
compared to the GLLSE-01, indicating that mycelial disruption using the homogenizer is
results in a better subsequent extraction. Both estimated and solids PS for 10 kDa
fractions are about half of 100 kDa fractions, indicating that large MW PS are lost during
separation.
Molar mass analysis
Molar mass analysis was performed to understand the differences between
the fractions of the PS extracts from GLLSE01-03 experiments and to confirm the
presence of target PS. Ethanol precipitated samples were used for GLLSE-02 100 kDa,
GLLSE-03 500 kDa, 100 kDa and 10 kDa fractions, whereas crude PS (without ethanol
extract) was used for GLLSE01 100 KDa fraction. All samples were prepared at 10
mg/mL.
Results indicated that all 100 kDa and 500 kDa fractions were somewhat
similar. The GLLSE-03100 kDa and 500 kDa are almost identical. The GLLSE-03 10 kDa
sample had less of the higher MW early eluting peak. The GLLSE-03 100 kDa sample also
had lower levels of high MW peaks. These chromatograms show that all samples are
significantly different from the AG standard extract. The most obvious feature is that the
GLLSE-01 100 kDa sample is dominated by a low MW peak, possibly a media ent.
Since crude PS of GLLSE-01 100 kDa (without ethanol precipitation) was used for
analysis, the resolution of the profile is not clear. This reiterates that an l
precipitation step is necessary before carrying out analysis using HPLC/Refractive index
systems. The standard shares with most samples a peak at 29 min but has a second
larger peak at 30 min. The standard shows only a slow increase in RI after 22 min rather
than the distinct peaks of the GLLSE-02 and GLLSE-03 samples. The GLLSE-02 and
GLLSE-03 s were quite similar while the GLLSE-01 100 kDa sample again is
different with weaker UV absorption. Using pullulan standards the fractions are predicted
to have PS of MW 0 kDa (at 19-21 min), 10-20 kDa (at 25-26 min) and 1-5 kDa
(at 29-30 min)
s analysis
s us described were used to measure glucans [7] with an
exception that crude PS (without ethanol precipitation) were used in this study. Results
te that about 7-10% β-glucans were present in all the fractions. A large % of -
glucans were also present and this could be due to elimination of ethanol precipitation
step, as this removes majority of low MW compounds (include media ents)
present in the PS extract liquid s. Therefore, the % of β-glucans could be much
higher if the ethanol precipitation step is used. However, it is important to note that
ethanol precipitation step may be ary if media components and other low MW
compounds are not desired in the product.
Table 14. Glucans analysis (avg±sd) on samples. The % is ve to the crude PS solids
except for GL027 (1-L batch) * where ethanol precipitated dry PS solids were used
Alpha glucan % (w/w) lucan % (w/w)
01 100 KDa 30.9 10.1
GLLSE-02 100 KDa 30.5±2.1 9.5±2.2
03 500 KDa 31.1±3 10±3
GLLSE-03 100 KDa 29.2±0.5 6.7±3.8
GLLSE-03 10 KDa 30.9±1.5 8±2.3
GL027 (previous 1-L batch) * 1.58±0.07 1.13
Triterpenes is
A qualitative analysis has been performed to compare the triterpene content
of the standard extract (SE) with the samples from the recent fermentation work. The
triterpenes are known to have UV absorption at 254 nm and can be seen in the crude
extract as peaks between 8 and 12 min. These peaks are also seen in an ethyl acetate
partition of the water soluble SE. LCMS shows this set of peaks have masses in the range
expected for penes. No such peaks are seen in the fermentation samples. Even
when the crude supernatant is ioned with a small amount of ethyl acetate no
triterpenes are seen. It may be concluded the triterpenes are not present in the
submerged fermentation samples. On the contrary, the crude terpene fraction represents
approx. 12% of the total extract weight of the SE.
Conclusions
The fermentation process was successfully scaled-up to 20 L bioreactors.
Biomass yields were higher than those reported in the previous example. al
disruption using the homogeniser (APV™ unit resulted in efficient tion of the PS
product. SEC-HPLC analysis indicated that the PS profiles of all the samples were ly
different from the standard extract, especially regarding a hump at ca. 8 min and
absence of second peak at ca. 10 min. Regardless, high PS yields were produced in this
study. Molar mass analysis confirmed the presence of low (1-5 kDa), medium (10-20
kDa) and high MW (100-200 kDa) PS in the ons, and using a suitable membrane
(500 kDa, 100 kDa and 10 kDa) desired MW PS can be extracted. Triterpenes were not
found in the biomass extracts, supernatants or dry PS solids.
. Example 5: Scale-up in two 200 L bioreactors
The purpose of this example is to examine a scaled up process. The
fermentation process was scaled up in 2 x 200 L bioreactors, run in parallel, and the
efficacy of previously developed downstream process operations were investigated.
.1 Methods
Fermentations were carried out in 2 x 200 L parallel bioreactors. GL030 was
run for 3 days and GL031 for 5 days. The biomass was then concentrated using hollow
fiber membranes (HFM) and mycelial disruption was carried out using high shear
homogenizer (M110P Microfluidizer®). Disrupted mycelial solution was then heated at
70 °C for 1 hr and filtered using a 500 kDa HFM. The crude PS was then freeze dried,
milled and stored in sealed bags with N2 headspace at –20°C.
Fermentation
rma seed medium (GSM), was used to expand the seed culture ofG.
lingzhi, and included, 40 g/L glucose, 4 g/L soy peptone, 1.5 g/L KH2PO4, and 1 g/L
MgSO4·7H2O. Ground rice bran (Lotus) was ed at a rate of 2% (w/v) to provide an
insoluble matrix to help diffuse mycelial growth in flasks. A three-stage seed train was
used to expand G. lingzhi. 4% (v/v) inoculum was used hout except for primary
seed where 2% (v/v) inoculum was used. Primary (1°) seed was prepared by ting
the 250 ml flask for 7 days at 30 °C and 140 RPM. Secondary (2°) seed was prepared in
four 1 L (400 mL working volume) flasks by incubating for 7 days at 30 °C and 140 RPM.
Tertiary seed (3°) was prepared in a 20-L bioreactor using the same seed media except
rice bran wasn’t added. The culture was agitated at 400 RPM and aerated at 20 LPM for
60 hrs (~2.5 days).
Production was carried out in 200 L bioreactors in duplicate as per Table 15.
To allow addition of condensate during SIP and addition of e bolus during the runs,
the final weights of both batches were lower than 200 L. Post-inoculation, the weights of
GL030 and GL031 were 190 kg and 171 kg, respectively.
Table 15. Fermentation conditions
200 L # Conditions Fermentation period
GL030 Agitation (200 RPM) and aeration (200 3 days
LPM), modified batch medium (glucose-50
g/L, peptone-10 g/L and yeast extract-5
g/L). Bolus of glucose (20 g/L/day) when
residual glucose drops <20 g/L
GLO31 Duplicate of GL030 5 days
By the end of fermentation, the pH of ry seed dropped to ~3.5,
similarly the final pH of GL030 and GL031 were 3.67 and 4.59, respectively. The pH of
GL031 dropped to 3.73 on day-3 and then increased to 4.59 by the end of the run (day-
). This ially indicates dimorphic growth of G. lingzhi, where the fungus switches
carbon sources. The fermentation profiles of both GL030 and GL031 were almost similar,
except GL030 had slightly longer lag phase.
Duplicate 50 mL samples of submerged biomass were taken on days 1, 2, 3,
4 and 5 and were centrifuged and oven-dried at 60 °C for 5-7 days to te dry cell
s (DCW) in g/L. DCW (g/L) of seeds were as s, 1° seed = 18.53 g/L, 2° seed
= 17.88 and 3° seed = 17.81 g/L.
The DCW (g/L) for GL030 and GL031 are shown in Table 16. The DCW for
GL030 and GL031 were similar for day 2 and day 3, but in GL031 the mycelial biomass
gradually increased to 23 g/L by the end of tation (day 5). Given, GL031 (5 day
fermentation) yielded higher biomass when compared to GL030 (3 day fermentation), a
day tation period is recommended. In general, for a typical 5 day fermentation
period, the dry biomass yields from this study are comparable to previous scaled-down
studies. The average DCW from 20 L study was 23 g/L, whereas 1 L study yielded 15 g/L
of dry s.
Table 16. DCW (g/L) of GL030 and GL031 over the production period
DCW g/L
Day GL030 GL031
1 4.9±0.15 10.1±0.15
2 15.9±0.24 17.7±0.09
3 15.7±0.12 15.3±0.14
4 18.5±0.10
22.4±0.19
Error shown in Table 16 is rd error. Mycelial mat formation was
evident in all the bioreactors (Figure 6), however much less foaming was noticed
compared to previous runs [6][7][8]. This indicates that antifoam 204 may be more
suitable for limiting foaming. Except for initial antifoam addition in batch media at
0.05 % (v/v), no antifoam addition was made during the run. In on, antifoam 204
doesn’t foul the HFM filters during concentration, whereas previously used silicon-based
Antifoam (Xiameter 1520) tended to foul the membrane filters. Antifoam 204 is therefore
recommended for future runs.
Data on residual glucose present in the supernatant samples of GL030 and
GL031 is shown in Table 17. Glucose bolus additions were not made during the run. By
the end of fermentation period, GL030 had 29.2 g/L of residual glucose and GL031 had
13 g/L. Similar profiles were seen in the previous 20 L study [8], where glucose was not
exhausted during the fermentation period.
Table 17. Residual glucose concentrations as measured using glucose measurement kit
during the tation period in GL030 and GL031 samples.
Day DCW g/L
GL030 GL031
1 45.6 40.5
2 32.4 36.8
3 29.2 34.8
4 26.2
13.0
Downstream process
GL030 was harvested on day-3 and GL031 on day 5. The biomass was
concentrated using a single, clean 500 kDa hollow fiber membrane (HFM). To collect the
residual biomass (retentate), the lines and membrane filter was rinsed with sterile
phosphate buffer solution. The s was then disrupted using a nizer
(Microfluidizer® M110p) at 2000 bar with a single pass. Disrupted mycelia were observed
under the microscope for confirmation of the extent of disruption. Disrupted mycelia were
then heated at 70 °C for 1 hr to allow PS to dissolve in the aqueous phase, which was
followed by filtration using a clean 500 kDa HFM. te (crude PS – liquid) was
collected and PBS was used to wash the retentate and the hose lines. The 500 kDa
fraction of liquid containing crude PS was then freeze dried (FD) in open trays using a
pilot scale freeze dryer over four batches. Due to presence of residual glucose, the solids
were very hygroscopic. FD crude PS solids were then milled and stored in sealed bags
with N2 headspace at –20 °C. GL030 yielded ~1.8 kg of crude PS, s GL031
yielded ~2.9 kg of crude PS (Table 18).
Table 18. Residual glucose concentrations as measured using glucose measurement kit
during the fermentation period in GL030 and GL031 samples.
GL030 GL031
Total wet biomass (kg) 190 170
Concentrated wet biomass (kg) 60.47 63.76
Permeate (PS 500 kDa) wet (500 kDa) 71.57 74.62
Freeze dried crude PS solids (kg) 1.84 2.99
Estimated FD crude PS solids (kg) per 9.7 17.5
1000 L batch
It was noted during the biomass tration of GL030, about 8-fold
concentration was achieved, however this led to accumulation of biomass in the retentate
side of the membrane filter.
Recirculation with PBS had little effect on ng the residual biomass. On
the other hand, GL031 biomass was concentrated only 3fold in order to limit loss of
biomass from the retentate side of the ne filter. Regardless, it was not possible
to collect all biomass from GL031 either. ore, to limit losses during concentration,
it is suggested to use alternate methods of concentration such as batch/continuous
centrifugation.
Representative samples (50 mL) of the biomass were taken on days 1-5, at
harvest and post trate and were processed using usly described analytical
methods to estimate target polysaccharide (PS) using HPLC method.
Microscopy images of samples taken during the fermentation period
suggested no evidence of contamination. The concentrated samples look stressed when
compared to the samples at harvest ting that the shear of membrane tubules might
be partially causing disruption of the mycelia resulting in loss of PS.
Polysaccharide analysis using SEC-HPLC
Previous work on ed samples using lar weight cut-off filters
(MWCO) showed that a ccharide concentration step was necessary to enhance the
polysaccharide concentration in each sample prior to analysis. However, this may not be
required during the manufacturing process. The methods used for PS analysis were as
described in the previous reports. Briefly, to 2 mL of sample, 8 mL of absolute l
was added, the sample was shaken and centrifuged, the pellet was resuspended in 0.5
mL water. After sonication and centrifugation, the resultant supernatant was used
directly for analysis.
Defatted extract of AG Standard extract was used to prepare the standard
curve. Some of AG standard was dissolved in 5 mL water and 3 mL ethyl acetate was
added and shaken. After fuging, lower aqueous layer was used as standard.
Previous reports showed that about 12% of the weight of the AG standard is lipid like,
and the concentration was adjusted accordingly.
The chromatograms of GL030 and GL031 samples on different days show a
similar e but different levels. The PS levels in post-concentration are significantly
lower than that in samples at harvest indicating that some of PS might have been lost
during the concentration step.
Samples processed at pilot scale were also analyzed using SEC-HPLC for
comparison. The chromatograms profiles clearly show that the crude PS fractions has the
target PS along with several low-medium molecular weight compounds.
The ethanol precipitated PS isolate is much cleaner as the ethanol wash
removes other low molecular weight compounds present in the crude PS.
The PS yields (mg per g of dry biomass) on days 3 and 5 of GL030 and
GL031 were found to be in the range of 120-150 mg/g and are comparable to previous
reports. PS yield dropped by ~50% in both GL030 and GL031 concentrate s
indicating loss of PS during concentration of s using HFM.
Using the SEC-HPLC method, it is estimated that a 1,000 L batch over 3 and
day fermentation period will produce 0.94 kg and 1.7 kg of “target PS”, respectively.
s analysis
Both GL030 and GL031 had approximately 26-27 % (w/w) of total glucans,
but no or very low amounts of β-glucans (0-1% w/w). The crude PS was then purified
using l precipitation and was used for total glucans analysis using the same kit.
Results indicated that GL030 had 1.78% (w/w) β-glucans and 7.18% (w/w) of β-glucans,
whereas GL031 had 1.38% (w/w) β -glucans and 6% (w/w) β-glucans as shown below in
Table 19.
Table 19. Glucans is on crude and (ethanol) ed PS s of GL030, GL031
in comparison with the previous study. * estimated based on β-glucans present in crude
GL030 GL031 GL029
(previous
study)
α-glucans (%) in crude PS 27 25 31
β-glucans (%) in crude PS <1% <1% 10%
α-glucans (%) in purified PS 1.8 1.4 –
β-glucans (%) in purified PS 7.2% 6% –
Total crude PS g/1,000 L batch 9700 17500 3600
Total purified PS g/1,000 L batch 942 1729 –
Estimated total β-glucans g/1,000 L 68 104 360*
batch
When ed to the previous study, the yields ofβ-glucans were lower in
GL030 and GL031 batches and it is anticipated due to loss of biomass during the
concentration step and (2) inefficient extraction of β-glucans during mycelial tion.
Both GL030 and GL031 mycelium had gone through one pass of disruption (at 2000 bar)
when ed to previous batch (GL029; GLLSE03) which went through three passes
(at 600 bar).
Conclusions
The fermentation process was successfully scaled-up to 200 L bioreactors.
GL030 yielded 15 g/L of dry biomass over 3 days of fermentation, whereas GL030
yielded 23 g/L of dry s over 5 days of fermentation. Concentration of biomass
using HFM may not be a suitable option due to the difficulties of collecting biomass and
potential loss of PS during filtration as strongly evidenced by PS yields.
The LC profiles of all samples were similar but differed in the levels of
PS. The crude PS includes PS that falls within the target molecular weight range in
addition to other dium molecular weight compounds. GL030 yielded 1.8 kg dry
crude PS, whereas GL031 produced 2.9 kg dry crude PS. It is estimated that a 1,000 L
batch over 5-day fermentation can produce 17.5 kg crude dry PS and 1.7 kg of target PS
(post ethanol wash). Both GL030 and GL031 had <1% β-glucans in crude PS samples but
on the contrary had 6-7% of β-glucans in (ethanol) purified PS samples indicating that
ethanol purified PS s must be used for estimation of β-glucans.
6. Example 6: Scale-up in 1,000 L bioreactor
The purpose of this e is to examine a scaled up s. The
fermentation process was scaled up in 1 x 1,000 L bioreactor with ream
processing operations to process the material to extract polysaccharides.
Since small molecules are of interest, it was decided to target crude
polysaccharide of ≤500 kDa t any ethanol g step. In a previous study the
fermentation process was scaled up and validated in 2 x 200 L bioreactors run in
parallel that differed in the harvest point. Fermentation until day 3 ed in 15 g/L
DCW, whereas 5 days fermentation resulted in 23 g/L dry biomass. Delayed growth was
identified, potentially due to impact of antifoam 204. Concentration of mycelial biomass
using tial flow filtration (TFF), a 500 kDa hollow fibre membrane (HFM) was not
efficient and lots of biomass could not be collected. About 6% (w/w) β-glucans were
present and it was anticipated that the number of passes though microfluidizer could
potentially increase the overall PS and ans yield.
In this study, the fermentation process was scaled up to 1,000 L and
demonstrated the downstream process at pilot scale. Due to high wet solids content
(20%/, w/w), continuous centrifuge was deemed not feasible. Instead, an integrated
approach was used by collecting bulk of mycelium using 74 µm sieve and HFM. About a
third of the biomass was retained for future trials. The remaining portion was processed
to extract PS.
6.1 Methods
Primary seed was cultured in 2 L flasks over 7 days at 30 °C and 140 RPM.
Secondary seed was cultured in 2 x 20 L bioreactors over imately 3 days.
Primary seed reached a dry cell weight (DCW) of 20.2±1 g/L and secondary
seed achieved a DCW of 14.2±6.4 g/L. Primary seed has a higher DCW due to addition of
2% (w/v) rice bran to keep the mycelia sed. 4% (v/v) ation was used
throughout.
The 1,000 L bioreactor was sterilised in place (SIP) and inoculated with 40 L
of ary seed. Foaming was autocontrolled using Xiameter 1520 AFE, and pH and
DO were not controlled. Fed-batch addition of glucose was not made. Fermentation was
carried out for five days with periodical sampling.
Upon harvest, s was sieved using a 74 µm sieve to collect bulk of the
mycelium, and the rest of the material was passed through a 500 kDa hollow fibre
ne (HFM) to collect remaining of the biomass.
Mycelial slurry was disrupted using a luidizer over three passes at 600-
900 bar, and then heat d at 70 °C, and passed through a 500 kDa HFM to collect
the polysaccharide (PS), which was then freeze dried, milled and vacuum packed.
Samples were analysed for DCW, polysaccharide (PS) content and profile
and β-glucans.
Fermentation was carried out in 1 x 1,000 L bioreactor over five days as per
conditions in Table 20. The downstream process is briefed in Figure 1.
Table 20. Fermentation conditions
1,000 L # Details Seed conditions
GL032 Similar to GLO31 (SOW6). Similar to GL030/31. Two
Agitation (upto 150 RPM) and aeration stage; Primary seed in flasks,
(up to 800 SLPM), modified batch medium and secondary seed in 2x 20 L
(glucose - 40 g/L). pH and DO were not bioreactors (400 RPM, 20 SLPM,
controlled. Auto foam control using pH and DO not controlled, seed
er 1520 AFE. media without rice bran.
Fermentation process
Ganoderma seed medium (GSM) was used to expand the seed culture ofG.
lingzhi, and ed 40 g/L e, 4 g/L soy peptone, 1.5 g/L KH2PO4, and 1 g/L
MgSO4·7H2O. Ground rice bran was included at a rate of 2% (w/v) to provide an
insoluble matrix to help diffuse mycelial . A age seed train was used to
expand G. lingzhi. Primary (1°) seed was prepared by inoculating 4x 500-mL GSM (2-L
flasks) with 2% (v/v) glycerol stock, and incubated for 7 days at 30 °C and 140 RPM.
Secondary (2°) seed was prepared in 2x 20-L bioreactors by sterilising in place (SIP)
using the GSM but without rice bran. The secondary seed was grown for ~3 days at
°C, 400 RPM, 20 SLPM, no pH and DO control.
Fermentation process and media conditions were as per Table 20. Fed-batch
glucose dosing was not made. Fermentation profiles of secondary seeds and production
batch (GL032) are shown in Figures 2 and 3.
Duplicate 50-mL samples of submerged biomass were taken on days 1, 2, 3,
4 and 5 and were centrifuged and dried in an oven at 60 °C for 4-5 days to estimate dry
cell weights (DCW) in g/L.
t DCW was seen on day 2 (17 g/L), and then it gradually decreased to
12.6 g/L by the end of fermentation period. The DCW of primary seed was higher due to
the presence of 2% (w/v) rice bran in the medium. Mycelial mat formation was evident
during the course of fermentation.
Using the CDR Beer lab kit, residual glucose was measured in supernatant
samples e 5). By the end of the tation period, about 8 g/L of glucose was
present.
Microscopic analysis of samples over the fermentation period was performed.
Contamination was not evident and typical mycelial growth was observed.
Downstream process
Downstream processing was started with 942 kg of mycelial biomass in the
bioreactor (Table 21). Using a 74 µm sieve, bulk of solids (mycelia) were ted and
the rest was passed through a 500 kDa HFM to t and concentrate biomass. About
2/3rds of the concentrated biomass (250 kg) was used for disruption by adding 104 kg of
water with a combined mass of 354 kg (16.8 g/L DCW) to e the fluid cs in
order to assist with mycelial disruption. The biomass was passed through a Microfluidizer
(APV™) at 600-900 bar three times. Samples were collected at the end of each pass to
confirm disruption under microscopy and later analysed for β-glucans. The disrupted
mycelia were then heat d at 70 °C and then cooled to 30 °C before passing it
through a 500 kDa HFM. The permeate was collected into a e tank, representative
samples were taken for analysis and stored in 60-L e drums and frozen. About 2
drums were retained for future trials, and the rest four drums were defrosted and freeze
dried over four batches in four weeks. The FD bulk material was then milled to
homogeneity in Robot Coupe® (R45) and packed in about 500-600 g vacuum sealed
bags to avoid moisture absorption of the product over storage.
Table 21. Downstream processing yields. *RO water (104 kg) was added to the biomass
(250 kg) to improve fluid dynamics
ream processing Processed (kg)
s at harvest 942
Concentrated biomass (sieved + HFM) 409 (250+157)
Concentrated biomass used for disruption* 250
Total PS extracted 210
Crude PS solids (freeze dried) 4.6
Estimated crude PS from a 1000 L fermentation 11.5
Estimated purified PS from a 1000 L fermentation 1.15
Polysaccharide and β-glucans analysis
usly described methods were used for extraction and analysis of PS
using HPLC, as described usly. Absolute ethanol was added to each sample to
precipitate polysaccharides (80% ethanol, v/v). Samples were centrifuged and the PS
pellet re-dissolved in water for analysis. Samples were re-dissolved in 2 mL water and
the concentrate samples (O-Q) re-dissolved in 10 mL water. Analysis was performed by
HPLC using a size exclusion gel column with ELS detection. The amount of PS in each
sample was ated from a standard curve prepared from the Alpha Group standard
PS sample. The standard was prepared by precipitation of the PS with 80% (v/v) ethanol.
Estimated PS mg/g of biomass is shown in Figure 8. PS production was
evident from day 1 and peaked on day 3 and was lowest on day 5. A GL032 concentrate
ned 82.7±7.2 (SD) mg/g PS.
Table 22. Estimated PS per dry gram of biomass based on HPLC peak areas (of target PS)
and actual total dry PS.
Sample Estimated PS mg/g
Primary seed 56.0±2.8
ary seed 157.5±17.7
GL032 Day 1 158.0±15.6
Day 2 180.0±35.4
Day 3 208.0±39.6
Day 4 181.5±2.1
Day 5 94.5±3.5
Glucans analysis
Methods usly described were used to measure glucans. s
indicated that about 6% (w/w) β-glucans were present in the purified PS samples,
whereas masking effect was seen in crude PS. The yields of β-glucan were r to
those of e 4 but lower when compared to those of Example 3 (~11%, w/w).
Table 23. Glucans analysis (avg±sd) on samples
Sample Total glucan (%, α-glucan (%, w/w) β- glucan (%, w/w)
Gl032 purified PS 6.75 ± 0.30 0.64 ± 0.02 6.11 ± 0.72
Gl032 crude PS 16.89 ± 0.55 18.42 ± 0.19 n.d.
Gl032 1st pass 5.85 ± 0.68 0.81 ± 0.08 5.05 ± 0.62
of disruption
Gl032 2nd pass 5.75 ± 0.82 0.76 ± 0.09 4.99 ± 0.67
of disruption
Gl032 3rd pass 6.05 ± 0.05 0.65 ± 0.07 5.40 ± 0.39
of disruption
6.2 Results
The fermentation process was successfully scaled up in 1,000 L bioreactor.
High DCW was evident on day 2, where the DCW decreased to 12 g/L by day 5. High PS
mg/g biomass was evident on day 3 and it halved by day 5. The PS profile was almost
similar to the AG standard. Microscopy indicated no contamination and typical mycelial
morphology was observed as seen in previous studies. Three passes of mycelial
disruption is ended at 600-900 bar.
Even though the batched media have lower concentrations of glucose than
the last study (50 vs 40 g/L), the residual glucose by the end of day 5 was at about 8
g/L, suggesting that more studies at 20 L or 1 L scale could allow the study of the impact
of lower concentrations of glucose in batched media on biomass and PS yield. Another
option is to perform ultrafiltration of the PS sample to remove glucose, however this step
may remove other small molecules t in the crude PS. ed analysis of
ents that are essential in the target PS product is recommended to be performed
by the Client before cing manufacturing.
Results indicated that:
The DCW of submerged biomass varied during the five day fermentation
period. Highest DCW was seen on day 2 (17±0.1 g/L) and the submerged
s decreased over the next few days to 12.6±1.5 g/L by day 5.
Batched glucose was consumed linearly over the course of fermentation
period, and by the end of day 5, about 8 g/L of residual glucose was
About 2.4 fold concentration was achieved using g and HFM, and
about 240 kg was used to disrupt, extract, purify and freeze dry to produce
7 kg of crude PS, an estimated 11.5 kg crude PS from a 1,000 L bioreactor.
HPLC analysis of pure PS profiles indicated similarity with standards, and
were inconsistent with previous runs.
High PS content was evident from day 2 to 4 (180-200 mg/g), however it
halved by day 5 (94 mg/g).
Analytical purification of crude PS with ethanol indicated that a pure PS is
approximately 10 % (w/w) of crude PS. This is estimated to be 1.15 kg of
pure PS from a 1000-L fermentation.
About 6.1% (w/w) ofβ-glucans, and 0.14% (w/w) of ��-glucans were present
in the pure PS.
WE
Claims (32)
1. A method for isolating intracellular polysaccharides from fungi comprising inoculating fungi into a tation medium, wherein the fermentation medium is subjected to agitation, extracting one or more polysaccharides from the mycelium by filtration, wherein the filtration has a pore size of a) about 1 to 5 kDa, b) about 10 to 20 kDa, c) about 100 to 200 kDa, d) or any combination of (a) to (c), and n the ccharides are extracted after about 3 to about 12 days of fermentation, to produce greater than 2% polysaccharide by weight of mycelium biomass.
2. A method of claim 1 wherein the agitation exerts a shear force of about 100 to about 1000 s-1.
3. A method of claim 1 or 2 comprising isolating mycelium from the fermentation medium.
4. A method of any one of claims 1 to 3 wherein the dosing of the media with sugar achieves a ratio of carbon to nitrogen of about 1:3.
5. A method of any one of claims 1 to 4 wherein the dosing of the media with sugar achieves a concentration of sugar in the media of about 20 g/L.
6. A method of any one of claims 1 to 5 wherein the sugar is provided to the media every 24 hours.
7. A method of any one of claims 1 to 6 wherein the sugar is first provided to the media after 24 hours from ation.
8. A method of any one of claims 1 to 7 wherein the sugar is glucose.
9. A method of any one of claims 1 to 8 wherein the agitation is high shear mixing.
10. A method of claim 9 wherein the fermentation is carried out at about 25 to about 35° C.
11. A method of any one of claims 1 to 10 wherein the fungi is a mushroom species.
12. A method of claim 11 wherein mushroom species may be selected from Inonotus obliquus, Trametes versicolor, (also known as us versicolor), Lentinula edodes, Hericium erinaceus, Cordyceps sinensis, Grifola frondosa, Schizophyllum commune, Flammulina velutipes, Pleurotus ostreatus, Agaricus bisporus, Auricularia la, Coprinus comatus, Phellinus linteus, or Laetiporus sulphureus.
13. A method of claim 12 wherein mushroom species is selected from Ganoderma lingzhi.
14. A method of any one of claims 1 to 13 wherein the mycelia comes from seed culture, and wherein the seed culture is first ed.
15. A method of any one of claims 1 to 14 wherein the concentration of seed culture at the beginning of fermentation is about 2 to about 6% by volume.
16. A method of claim 14 or 15 wherein the seed culture is a ation of preexisting and expanded seed culture.
17. A method of any one of claims 1 to 16 n the inoculated media is incubated for up to 7 days.
18. A method of any one of claims 1 to 17 wherein the inoculated media is stirred.
19. A method of claim 18 wherein the inoculated media is stirred at about 80 to 160
20. A method of any one of claims 1 to 19 n the media comprises: a) about 30 to 50 g/L glucose, b) about 2 to 6 g/L soy peptone, c) about 1 to 3 g/L KH2PO4, d) about 0.5 to 2 g/L 7H2O, or e) any combination of (a) to (d).
21. A method of any one of claims 1 to 20 wherein the method comprises the addition of insoluble ingredient.
22. A method of claim 21 comprising about 0.5 to about 4% w/v of insoluble ingredient.
23. A method of claim 21 or 22 n the insoluble ingredient is lotus ground rice bran.
24. A method of any one of claims 1 to 23 wherein the vessel used for fermentation is a bioreactor.
25. A method of any one of claims 1 to 24 wherein the method controls any one or more parameters selected from pH, ved oxygen, on, and shear force.
26. A method of any one of claims 1 to 25 wherein the mycelia is harvested before fruiting body formation.
27. A method of any one of claims 1 to 26 wherein the pH of the media is about 3 to
28. A method of any one of claims 1 to 27 wherein the level of oxygen in the fermentation mixture may be about 20 to about 30%.
29. A method of any one of claims 1 to 28 sing the addition of an anti-foam agent to the media.
30. A method of any one of claims 1 to 29 wherein the biomass is dried prior to extraction.
31. A method of any one of claims 1 to 30 wherein the method extracts at least 5% polysaccharide per dry weight of the biomass.
32. A isolate from a fungal biomass, the isolate comprising two or more polysaccharides having a molecular mass selected from about 1 to about 5 kDa, about 10 to about 20 kDa, and about 100 to about 200 kDa.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2020904883 | 2020-12-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ785215A true NZ785215A (en) | 2022-02-25 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2272876B1 (en) | Glucan and mannan, their preparation method and use | |
CN108118003B (en) | Black yeast, culture medium and method for producing beta-glucan, and black yeast culture and composition containing beta-glucan | |
AU2023201749B2 (en) | Isolating intracellular polysaccharides from fungi | |
JP2021000083A (en) | Panax ginseng-lycium chinense fermented liquid and preparation method thereof | |
Zerva et al. | Valorization of Olive Mill Wastewater for the Production of β-glucans from Selected Basidiomycetes | |
CN107189949B (en) | Rhizopus oryzae LJH3 and application thereof in preparation of genistein by biotransformation of sophoricoside | |
CN108753900A (en) | A kind of method that the fermentation of ginseng endophyte prepares rare ginsenoside | |
KR101564487B1 (en) | Manufacturing method of small molecule Ginsenoside | |
CN117925731A (en) | Galactose yeast-like fungus centella asiatica fermentation product and preparation method and application thereof | |
CN110777135A (en) | Fermentation method for high yield of β -glucan based on sparassis crispa | |
CN107893033B (en) | Aspergillus fumigatus SQH4 and application thereof in preparation of taxifolin by biotransformation method | |
KR101641284B1 (en) | Methods for Preparing Fermented Ginseng or Red Ginseng Enriched Rg3(S) | |
CN111437224B (en) | Method for extracting antioxidant component from cannabis sativa leaves by using microorganisms and application of antioxidant component | |
NZ785215A (en) | Isolating intracellular polysaccharides from fungi | |
KR102244275B1 (en) | Method for Preparation of Bioconverted Red Ginseng with Enhanced compound K content | |
CN115216511B (en) | Method for preparing rare saponin by fermenting and converting notoginsenoside R1 with lactobacillus plantarum | |
CN112094762B (en) | Corynebacteria vinifera strain and application thereof | |
CN110810804A (en) | Preparation method of kelp biological salt | |
CN111345419A (en) | Compound fermentation type shark cartilage powder health drink | |
CN105199966B (en) | A kind of conversion ginsenoside Rb1 produces aspergillus and the application of Rd | |
CN113121714B (en) | Ganoderma lucidum oligosaccharide with probiotic activity and preparation method and application thereof | |
WO2013155865A1 (en) | Method for increasing yield of total triterpene compounds in phellinus igniarius | |
CN114250252B (en) | Method for preparing multifunctional glycerin by fermenting raisins | |
CN114369558B (en) | Serratia marcescens and application thereof in naringinase production | |
CN114921510B (en) | Application of paecilomyces coral in extraction of polysaccharide from radix cynanchi bungei |